Document:

SUBSCRIPTION
AGREEMENT

       

      THIS SUBSCRIPTION AGREEMENT
(this “Agreement”), is
dated as of January 20, 2010, by and between Weikang Bio-Technology Group
Company, Inc., a Nevada corporation (the “Company”), and the subscribers
identified on the signature pages hereto (each a “Subscriber” and collectively,
the “Subscribers”).

      

      RECITALS:

      

      WHEREAS, the Company and the
Subscribers are executing and delivering this Agreement in reliance upon an
exemption from securities registration afforded by the provisions of Section
4(2), Section 4(6), Regulation D (“Regulation D”) and/or
Regulation S (“Regulation
S”) as promulgated by the United States Securities and Exchange
Commission (the “Commission”) under the
Securities Act of 1933, as amended (the “1933 Act”).

      

      WHEREAS, Hunter Wise
Securities, LLC is acting as exclusive placement agent (“Placement Agent”), on a “best
efforts” basis, in a private offering (the “Offering”) in which the
Subscribers agree to purchase and the Company agrees to offer and sell shares of
its common stock (the “Purchased Shares”) at a price
of $1.70 per share (the “Share
Purchase Price”) for aggregate gross proceeds of up to $5,000,000 (the
“Purchase
Price”).

       

      WHEREAS, in connection with
the Offering, the Company grants the Opus Holdings Three, Ltd. (“Opus Holdings”) the exclusive
right to purchase any remaining Purchased Shares in any Subsequent Closing (as
defined herein) until the Final Closing Date. Opus Holdings shall have the right
to approve any additional subscribers in the Offering.

       

      WHEREAS, in connection with
the Offering, the Company shall issue to the Subscribers Series A share purchase
warrants (the “Series A
Warrants”) in the form attached hereto as Exhibit F and Series B share
purchase warrants (the “Series
B Warrants”) in the form attached hereto as Exhibit G (collectively, the
“Warrants”), with the Series A Warrants
entitling the Subscribers to purchase one (1) share of the Company’s Common
Stock (the “A Warrant Shares”) for every
Eight Dollars ($8.00) paid by the Subscriber for Purchased Shares, and with the
Series B Warrants entitling the Subscribers to purchase one (1) share of the
Company’s Common Stock (the “B
Warrant Shares”) (collectively, the A Warrant Shares and the B Warrant
Shares, the “Warrant
Shares”) for every Eight Dollars ($8.00) paid by the Subscriber for
Purchased Shares (collectively the  Purchased Shares and Warrants
are  referred to as the “Purchased
Securities”).

       

      WHEREAS, the Company desires
to enter into this Agreement to issue and sell the Purchased Securities and the
Subscriber desires to purchase that number of Purchased Securities set forth on
the signature page hereto on the terms and conditions set forth
herein.

      
        
           

        

        
          1

          
            

          

        

        
           

        

      

      WHEREAS, the aggregate
proceeds of the Offering shall be held in escrow pursuant to the terms of a
Funds Escrow Agreement to be executed by the parties substantially in the form
attached hereto as Exhibit
A (the “Escrow
Agreement”).

       

      AGREEMENT:

       

      NOW, THEREFORE, in
consideration of the mutual covenants and other agreements contained in this
Agreement, the Company and the Subscriber hereby agree as follows:

       

      1.           Purchase and Sale of
Purchased Securities.

       

      (a)           The Purchased
Shares.   Subject to the satisfaction or waiver of the
terms and conditions of this Agreement, on the Closing Date (as defined below),
each Subscriber shall purchase and the Company shall sell to each Subscriber the
Purchased Shares for the portion of the Purchase Price designated on the
signature pages hereto.

      

      (b)           Warrants. Upon the
following terms and conditions and for no additional consideration, each of the
Subscribers shall be issued Series A Warrants in the form attached hereto as
Exhibit F and Series B
Warrants in the form attached hereto as Exhibit G with the Series A
Warrants entitling the Subscribers to purchase one (1) share of the Company’s
Common Stock for every Eight Dollars ($8.00) paid by the Subscriber for
Purchased Shares, and the Series B Warrants entitling the Subscribers to
purchase one (1) share of the Company’s Common Stock for every Eight Dollars
($8.00) paid by the Subscriber for Purchased Shares as set forth on the
signature pages hereto. The Warrants shall expire three (3) years following the
Closing Date, and the Series A Warrants and Series B Warrants shall have an
initial exercise price of $3.00 and $5.00 respectively.

       

      2.           Closing.  The
issuance and sale of the Purchased Securities shall occur on the closing date
(the “Closing Date”),
which shall be the date that Subscriber funds representing the net amount due to
the Company from the Purchase Price of the Offering is transmitted by wire
transfer or otherwise to or for the benefit of the Company. The initial Closing
Date shall occur on or before January 20, 2010 (the “Initial Closing”) and shall
transmit to the Company gross proceeds of at least $2,500,000. In addition, the
Subscriber and the Company acknowledge and agree that Opus Holdings shall have
the exclusive right to purchase any remaining Purchased Shares in subsequent
closings (a “Subsequent
Closing”) on or before February 23, 2010 (the “Final Closing Date”). Opus
Holdings shall have the right to approve any additional subscribers in the
Offering.  The consummation of the transactions contemplated herein
(the “Closing”) shall
take place at the offices of Anslow & Jaclin, LLP, 195 Route 9 South, 2nd Floor,
Manalapan, New Jersey 07726 on such date and time as the Subscribers and the
Company may agree upon; provided, that all of
the conditions set forth in Section 11 hereof and applicable to the Closing
shall have been fulfilled or waived in accordance herewith. The Subscriber and
the Company acknowledge and agree that the Company may consummate the sale of
additional Purchased Securities to the Subscriber, on the terms set forth in
this Agreement and the other Transaction Documents as defined herein, at more
than one closing (each referred to herein as a “Closing”).

       

      
        
           

        

        
          2

          
            

          

        

        
           

        

      

      

      3.           Subscriber Representations,
Warranties and Covenants.  The Subscriber hereby represents and
warrants to and agrees with the Company that:

      

      (a)           Organization and Standing of
the Subscriber.   If such Subscriber is an entity, such
Subscriber is a corporation, partnership or other entity duly incorporated or
organized, validly existing and in good standing under the laws of the
jurisdiction of its incorporation or organization.

      

      (b)           Authorization and
Power.   Such Subscriber has the requisite power and
authority to enter into and perform this Agreement and the other Transaction
Documents (as defined in Section 4(c)) and to purchase the Purchased Securities
being sold to it hereunder.  The execution, delivery and performance
of this Agreement and the other Transaction Documents by such Subscriber and the
consummation by it of the transactions contemplated hereby and thereby have been
duly authorized by all necessary corporate or partnership action, and no further
consent or authorization of such Subscriber or its Board of Directors,
stockholders, partners, members, as the case may be, is
required.  This Agreement and the other Transaction Documents have
been duly authorized, executed and delivered by such Subscriber and constitutes,
or shall constitute when executed and delivered, a valid and binding obligation
of such Subscriber enforceable against such Subscriber in accordance with the
terms thereof.

      

      (c)           No
Conflicts.   The execution, delivery and performance of
this Agreement and the other Transaction Documents and the consummation by such
Subscriber of the transactions contemplated hereby and thereby or relating
hereto do not and will not (i) result in a violation of such Subscriber’s
charter documents or bylaws or other organizational documents or (ii) conflict
with, or constitute a default (or an event which with notice or lapse of time or
both would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of any agreement, indenture or
instrument or obligation to which such Subscriber is a party or by which its
properties or assets are bound, or result in a violation of any law, rule, or
regulation, or any order, judgment or decree of any court or governmental agency
applicable to such Subscriber or its properties (except for such conflicts,
defaults and violations as would not, individually or in the aggregate, have a
material adverse effect on such Subscriber).  Such Subscriber is not
required to obtain any consent, authorization or order of, or make any filing or
registration with, any court or governmental agency in order for it to execute,
deliver or perform any of its obligations under this Agreement and the other
Transaction Documents or to purchase the Purchased Securities in accordance with
the terms hereof, provided that for purposes of the representation made in this
sentence, such Subscriber is assuming and relying upon the accuracy of the
relevant representations and agreements of the Company herein.

      
        
           

        

        
          3

          
            

          

        

        
           

        

      

      

      (d)           Acquisition for
Investment. The Subscriber is acquiring the Purchased Securities solely
for its own account for the purpose of investment and not with a view to or for
resale in connection with a distribution.  The Subscriber does not
have a present intention to sell the Purchased Securities, nor a present
arrangement (whether or not legally binding) or intention to effect any
distribution of the Purchased Securities to or through any person or entity;
provided, however, that by
making the representations herein and subject to Section 3.2(h) below, the
Subscriber does not agree to hold the Purchased Securities for any minimum or
other specific term and reserves the right to dispose of the Purchased
Securities at any time in accordance with Federal and state securities laws
applicable to such disposition.  The Subscriber acknowledges that it
is able to bear the financial risks associated with an investment in the
Purchased Securities and that it has been given full access to such records of
the Company and the subsidiaries and to the officers of the Company and the
subsidiaries and received such information as it has deemed necessary or
appropriate to conduct its due diligence investigation and has sufficient
knowledge and experience in investing in companies similar to the Company in
terms of the Company’s stage of development so as to be able to evaluate the
risks and merits of its investment in the Company.  The Subscriber
further acknowledges that the Subscriber understands the risks of investing in
companies domiciled and/or which operate primarily in the People’s Republic of
China and that the purchase of the Purchased Securities involves substantial
risks.

      

      (e)           Information on
Company.    Such Subscriber has been furnished with
or has had access to the EDGAR Website of the Commission and to the Company’s
Form 10-K filed on EDGAR on April 15, 2009 for the fiscal year ended December
31, 2008, together with all other filings made with the Commission available at
the EDGAR website (hereinafter referred to collectively as the “Reports”) and all
correspondence from the Commission to the Company including but not limited to
the Commission’s comment letters relating to the Company’s periodic filings with
the Commission whether available at the EDGAR website or not.  In
addition, such Subscriber has received in writing from the Company such other
information concerning its operations, financial condition and other matters as
such Subscriber has requested in writing, identified thereon as OTHER WRITTEN
INFORMATION (such other information is collectively, the “Other Written Information”),
and considered all factors such Subscriber deems material in deciding on the
advisability of investing in the Purchased Securities.  Such
Subscriber has relied on the Reports and Other Written Information in making its
investment decision.

      

      (f)
           Opportunities for Additional
Information.  The Subscriber acknowledges that the Subscriber
has had the opportunity to ask questions of and receive answers from, or obtain
additional information from, the executive officers of the Company concerning
the financial and other affairs of the Company.

      

      (g)           Information on
Subscriber.   Subscriber is, and will be on the Closing
Date, an “accredited
investor”, as such term is defined in Regulation D promulgated by the
Commission under the 1933 Act, is experienced in investments and business
matters, has made investments of a speculative nature and has purchased
securities of United States publicly-owned companies in private placements in
the past and, with its representatives, has such knowledge and experience in
financial, tax and other business matters as to enable such Subscriber to
utilize the information made available by the Company to evaluate the merits and
risks of and to make an informed investment decision with respect to the
proposed purchase, which represents a speculative investment.  Such
Subscriber has the authority and is duly and legally qualified to purchase and
own the Purchased Securities.  Such Subscriber is able to bear the
risk of such investment for an indefinite period and to afford a complete loss
thereof.  The information set forth on the signature page hereto
regarding such Subscriber is accurate.

      
        
           

        

        
          4

          
            

          

        

        
           

        

      

      

      (h)           Compliance with 1933
Act.   Such Subscriber understands and agrees that the
Purchased Securities have not been registered under the 1933 Act or any
applicable state securities laws, by reason of their issuance in a transaction
that does not require registration under the 1933 Act (based in part on the
accuracy of the representations and warranties of the Subscriber contained
herein), and that such Purchased Securities must be held indefinitely unless a
subsequent disposition is registered under the 1933 Act or any applicable state
securities laws or is exempt from such registration.  The Subscriber
acknowledges that the Subscriber is familiar with Rule 144 of the rules and
regulations of the Commission, as amended, promulgated pursuant to the
Securities Act (“Rule
144”), and that such person has been advised that Rule 144 permits
resales only under certain circumstances. The Subscriber understands that to the
extent that Rule 144 is not available, the Subscriber will be unable to sell any
Purchased Securities without either registration under the 1933 Act or the
existence of another exemption from such registration requirement. In any event,
and subject to compliance with applicable securities laws, the Subscriber may
enter into lawful hedging transactions in the course of hedging the position
they assume and the Subscriber may also enter into lawful short positions or
other derivative transactions relating to the Purchased Securities, and deliver
the Purchased Securities, to close out their short or other positions or
otherwise settle other transactions, or loan or pledge the Purchased Securities,
to third parties who in turn may dispose of these Purchased
Securities.

      

      (i)
           Purchased Securities
Legend.  The Purchased Securities shall bear the following or
similar legend:

      

      “THE ISSUANCE AND SALE OF THE
PURCHASED SECURITIES REPRESENTED BY THIS CERTIFICATE HAS
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR APPLICABLE
STATE SECURITIES LAWS.  THE PURCHASED SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD,
TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE
PURCHASED SECURITIES UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE
HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER
SAID ACT
OR  PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT, OR OTHERWISE.  NOTWITHSTANDING THE
FOREGOING, THE PURCHASED
SECURITIES MAY BE PLEDGED IN CONNECTION WITH A
BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE
PURCHASED SECURITIES.”

      
        
           

        

        
          5

          
            

          

        

        
           

        

      

       

      (j)
           Communication of
Offer.  The offer to sell the Purchased Securities was directly
communicated to such Subscriber by the Company.  At no time was such
Subscriber presented with or solicited by any leaflet, newspaper or magazine
article, radio or television advertisement, or any other form of general
advertising or solicited or invited to attend a promotional meeting otherwise
than in connection and concurrently with such communicated offer.

      

      (k)           Restricted
Securities.   Such Subscriber understands that the
Purchased Securities have not been registered under the 1933 Act and such
Subscriber will not sell, offer to sell, assign, pledge, hypothecate or
otherwise transfer any of the Purchased Securities unless pursuant to an
effective registration statement under the 1933 Act, or unless an exemption from
registration is available.  Notwithstanding anything to the contrary
contained in this Agreement, such Subscriber may transfer (without restriction
and without the need for an opinion of counsel) the Purchased Securities to its
Affiliates (as defined below) provided that each such Affiliate is an
“accredited investor” under Regulation D and such Affiliate agrees to be bound
by the terms and conditions of this Agreement. For the purposes of this
Agreement, an “Affiliate” of any person or
entity means any other person or entity directly or indirectly controlling,
controlled by or under direct or indirect common control with such person or
entity.  Affiliate includes each Subsidiary of the Company.  For
purposes of this definition, “control” means the power to
direct the management and policies of such person or firm, directly or
indirectly, whether through the ownership of voting securities, by contract or
otherwise.

      

      (l)
           No Governmental
Review.   Such Subscriber understands that no United
States federal or state agency or any other governmental or state agency has
passed on or made recommendations or endorsement of the Purchased Securities or
the suitability of the investment in the Purchased Securities nor have such
authorities passed upon or endorsed the merits of the offering of the Purchased
Securities.

      

      (m)          Correctness of
Representations.  Such Subscriber represents that the foregoing
representations and warranties are true and correct as of the date hereof and,
unless such Subscriber otherwise notifies the Company prior to the Closing Date,
shall be true and correct as of the Closing Date.  The Subscriber
understands that the Purchased Securities are being offered and sold in reliance
on a transactional exemption from the registration requirement of Federal and
state securities laws and the Company is relying upon the truth and accuracy of
the representations, warranties, agreements, acknowledgments and understandings
of the Subscriber set forth herein in order to determine the applicability of
such exemptions and the suitability of the Subscriber to acquire the Purchased
Securities.

      
        
           

        

        
          6

          
            

          

        

        
           

        

      

      

      (n)           Short Sales and
Confidentiality. Other than the transaction contemplated hereunder, the
Subscriber has not directly or indirectly, nor has any person acting on behalf
of or pursuant to any understanding with the Subscriber, executed any
disposition, including short sales (but not including the location and/or
reservation of borrowable shares of Common Stock), in the securities of the
Company during the period commencing from the time that the Subscriber first
received a term sheet from the Company or any other person setting forth the
material terms of the transactions contemplated hereunder until the date that
the transactions contemplated by this Agreement are first publicly announced as
described in Section 7(m).  The Subscriber covenants that until such
time as the transactions contemplated by this Agreement are publicly disclosed
by the Company as described in Section 7(m), the Subscriber will maintain the
confidentiality of all disclosures made to it in connection with this
transaction (including the existence and terms of this transaction). The
Subscriber understands and acknowledges that the Commission currently takes the
position that coverage of short sales of shares of the Common Stock “against the
box” prior to the effective date of the Registration Statement with the
Purchased Securities is a violation of Section 5 of the 1933 Act, as set forth
in Item 65, Section 5 under Section A, of the Manual of Publicly Available
Telephone Interpretations, dated July 1997, compiled by the Office of Chief
Counsel, Division of Corporation Finance. Notwithstanding the foregoing, the
Subscriber does not make any representation, warranty or covenant hereby that it
will not engage in short sales in the securities of the Company after the date
that the transactions contemplated by this Agreement are first publicly
announced as described in Section 7(m). Notwithstanding the foregoing, in the
case of a Subscriber that is a multi-managed investment vehicle whereby separate
portfolio managers manage separate portions of such Subscriber's assets and the
portfolio managers have no direct knowledge of the investment decisions made
by the portfolio managers managing other portions of such Subscriber's
assets, the covenant set forth above shall only apply with respect to the
portion of assets managed by the portfolio manager that made the investment
decision to purchase the Purchased Securities covered by this
Agreement.

      

      (o)           Additional
Representations, Warranties and Covenants of Non-United States
Persons.

      

      (i)           The
Subscriber understands that the investment offered hereunder has not been
registered under the 1933 Act and the Subscriber understands that such
Subscriber is purchasing the Purchased Securities without being furnished any
offering literature or prospectus. The Subscriber is acquiring the Purchased
Securities for the Subscriber’s own account, for investment purposes only, and
not with a view towards resale or distribution.

      

      (ii)          At
the time the Subscriber was offered the Purchased Securities, it was not, and at
the date hereof, such Subscriber is not a “U.S. Person”
which is defined below:

      

      
        	
              	
                (A)

              	
                Any
      natural person resident in the United
States;

              

      

      

      
        	
                 
      

              	
                (B)

              	
                Any
      partnership or corporation organized or incorporated under the laws of the
      United States;

              

      

      

      
        	
                 
      

              	
                (C)

              	
                Any
      estate of which any executor or administrator is a U.S.
      person;

              

      

      

      
        	
              	
                (D)

              	
                Any
      trust of which any trustee is a U.S.
person;

              

      

      

      
        	
                 
      

              	
                (E)

              	
                Any
      agency or branch of a foreign entity located in the United
      States;

              

      

      
        
           

        

        
          7

          
            

          

        

        
           

        

      

      

      
        	
                 
      

              	
                (F)

              	
                Any
      non-discretionary account or similar account (other than an estate or
      trust) held by a dealer or other fiduciary for the benefit or account of a
      U.S. person;

              

      

      

      
        	
                 
      

              	
                (G)

              	
                Any
      discretionary account or similar account (other than an estate or trust)
      held by a dealer or other fiduciary organized, incorporated, or (if an
      individual) resident of the United States;
and

              

      

      

      
        	
                 
      

              	
                (H)

              	
                Any
      partnership or corporation if (i) organized or incorporated under the laws
      of any foreign jurisdiction and (ii) formed by a U.S. person principally
      for the purpose of investing in securities not registered under the 1933
      Act, unless it is organized or incorporated, and owned, by accredited
      investors (as defined in Rule 501(a) of Regulation D promulgated under the
      1933 Act) who are not natural persons, estates or
  trusts.

              

      

      

      “United States” or “U.S.” means the United
States of America, its territories and possessions, any State of the United
States, and the District of Columbia.

      

      (iii)         The
Subscriber understands that no action has been or will be taken in any
jurisdiction by the Company that would permit a public offering of the Purchased
Securities in any country or jurisdiction where action for that purpose is
required.

      

      (iv)         The
Subscriber (i) as of the execution date of this Agreement is not located within
the United States, and (ii) is not purchasing the Purchased Securities for the
account or benefit of any U.S. person except in accordance with one or more
available exemptions from the registration requirements of the 1933 Act or in a
transaction not subject thereto.

      

      (v)          The
Subscriber will not resell the Purchased Securities except in accordance with
the provisions of Regulation S (Rule 901 through 905 and Preliminary Notes
thereto), pursuant to a registration under the 1933 Act, or pursuant to an
available exemption from registration; and agrees not to engage in hedging
transactions with regard to such securities unless in compliance with the 1933
Act.

      

      (vi)         The
Subscriber will not engage in hedging transactions with regard to shares of the
Company prior to the expiration of the distribution compliance period specified
in Category 2 or 3 (paragraph (b)(2) or (b)(3)) in Rule 903 of Regulation S, as
applicable, unless in compliance with the 1933 Act; and as applicable, shall
include statements to the effect that the securities have not been registered
under the 1933 Act and may not be offered or sold in the United States or to
U.S. persons (other than distributors) unless the securities are registered
under the 1933 Act, or an exemption from the registration requirements of the
1933 Act is available.

      
        
           

        

        
          8

          
            

          

        

        
           

        

      

      

      (vii)        No
form of “directed selling efforts” (as defined in Rule 902 of Regulation S under
the 1933 Act), general solicitation or general advertising in violation of the
1933 Act has been or will be used nor will any offers by means of any directed
selling efforts in the United States be made by the Subscriber or any of their
representatives in connection with the offer and sale of the Purchased
Securities.

       

      4.           Company Representations and
Warranties.  The Company represents and warrants to and agrees
with each Subscriber that:

       

      (a)           Due
Incorporation.  The Company is a corporation or other entity
duly incorporated or organized, validly existing and in good standing under the
laws of the jurisdiction of its incorporation or organization and has the
requisite corporate power to own its properties and to carry on its business as
presently conducted.  The Company is duly qualified as a foreign
corporation to do business and is in good standing in each jurisdiction where
the nature of the business conducted or property owned by it makes such
qualification necessary, other than those jurisdictions in which the failure to
so qualify would not have a Material Adverse Effect.  For purposes of
this Agreement, a “Material
Adverse Effect” means any material adverse effect on the business,
operations, properties, or financial condition of the Company and its
Subsidiaries individually, or in the aggregate and/or any condition,
circumstance, or situation that would prohibit or otherwise materially interfere
with the ability of the Company to perform any of its obligations under this
Agreement in any material respect. For purposes of this Agreement, “Subsidiary” means, with
respect to any entity at any date, any corporation, limited or general
partnership, limited liability company, trust, estate, association, joint
venture or other business entity of which more than 30% of (i) the
outstanding capital stock having (in the absence of contingencies) ordinary
voting power to elect a majority of the board of directors or other managing
body of such entity, (ii) in the case of a partnership or limited liability
company, the interest in the capital or profits of such partnership or limited
liability company or (iii) in the case of a trust, estate, association,
joint venture or other entity, the beneficial interest in such trust, estate,
association or other entity business is, at the time of determination, owned or
controlled directly or indirectly through one or more intermediaries, by such
entity.  As of the Closing Date, all of the Company’s Subsidiaries and
the Company’s ownership interest therein are set forth on Schedule 4(a).

       

      (b)           Outstanding
Stock.  All issued and outstanding shares of capital stock and
equity interests in the Company have been duly authorized and validly issued and
are fully paid and non-assessable.

       

      (c)           Authority;
Enforceability.  This Agreement, the Purchased
Securities, the Escrow Agreement, the Investor Relations Escrow
Agreement,  the Lock-Up Agreements and any other agreements delivered
together with this Agreement or in connection herewith (collectively, the “Transaction Documents”) have
been duly authorized, executed and delivered by the Company and are valid and
binding agreements of the Company enforceable in accordance with their terms,
subject to bankruptcy, insolvency, fraudulent transfer, reorganization,
moratorium and similar laws of general applicability relating to or affecting
creditors’ rights generally and to general principles of equity.  The
Company has full corporate power and authority necessary to enter into and
deliver the Transaction Documents and to perform its obligations
thereunder.

      
        
           

        

        
          9

          
            

          

        

        
           

        

      

       

      (d)           Capitalization and Additional
Issuances.   The authorized and outstanding capital stock
of the Company and Subsidiaries on a fully diluted basis as of the date of this
Agreement and the Closing Date (not including the Purchased Securities) are set
forth on Schedule 4(d).  Except as set
forth on Schedule 4(d), there are no options,
warrants, or rights to subscribe to, securities, rights, understandings or
obligations convertible into or exchangeable for or giving any right to
subscribe for any shares of capital stock or other equity interest of the
Company or any of the Subsidiaries.  The only officer, director,
employee and consultant stock option or stock incentive plan or similar plan
currently in effect or contemplated by the Company is described on Schedule
4(d).  There are no outstanding agreements or preemptive or
similar rights affecting the Company’s common stock.

       

      (e)           Consents.  No
consent, approval, authorization or order of any court, governmental agency or
body or arbitrator having jurisdiction over the Company, or any of its
Affiliates, the Over The Counter Bulletin Board (the “Bulletin Board”) or the
Company’s shareholders is required for the execution by the Company of the
Transaction Documents and compliance and performance by the Company of its
obligations under the Transaction Documents, including, without limitation, the
issuance and sale of the Purchased Securities.  The Transaction
Documents and the Company’s performance of its obligations thereunder have been
unanimously approved by the Company’s Board of Directors.  No consent,
approval, order or authorization of, or registration, qualification,
designation, declaration or filing with, any governmental authority in the
world, including without limitation, the United States, or elsewhere is required
by the Company or any Affiliate of the Company in connection with the
consummation of the transactions contemplated by this Agreement, except as would
not otherwise have a Material Adverse Effect or the consummation of any of the
other agreements, covenants or commitments of the Company or any Subsidiary
contemplated by the other Transaction Documents. Any such qualifications and
filings will, in the case of qualifications, be effective on the Closing and
will, in the case of filings, be made within the time prescribed by
law.

       

      (f)           No Violation or
Conflict.  Assuming the representations and warranties of the
Subscriber in Section 3 are true and correct, neither the issuance nor sale of
the Purchased Securities nor the performance of the Company’s obligations under
this Agreement and all other Transaction Documents entered into by the Company
relating thereto will:

       

      (i)           violate,
conflict with, result in a breach of, or constitute a default (or an event which
with the giving of notice or the lapse of time or both would be reasonably
likely to constitute a default) under (A) the articles or certificate of
incorporation, charter or bylaws of the Company, (B) to the Company’s knowledge,
any decree, judgment, order, law, treaty, rule, regulation or determination
applicable to the Company of any court, governmental agency or body, or
arbitrator having jurisdiction over the Company or over the properties or assets
of the Company or any of its Affiliates, (C) the terms of any bond, debenture,
note or any other evidence of indebtedness, or any agreement, stock option or
other similar plan, indenture, lease, mortgage, deed of trust or other
instrument to which the Company or any of its Affiliates is a party, by which
the Company or any of its Affiliates is bound, or to which any of the properties
of the Company or any of its Affiliates is subject, or (D) the terms of any
“lock-up” or similar provision of any underwriting or similar agreement to which
the Company, or any of its Affiliates is a party except the violation, conflict,
breach, or default of which would not have a Material Adverse Effect;
or

      
        
           

        

        
          10

          
            

          

        

        
           

        

      

       

      (ii)          result
in the creation or imposition of any lien, charge or encumbrance upon the
Purchased Securities or any of the assets of the Company or any of its
Affiliates except in favor of Subscriber as described herein; or

       

      (iii)         result
in the activation of any anti-dilution rights or a reset or repricing of any
debt, equity or security instrument of any creditor or equity holder of the
Company, or the holder of the right to receive any debt, equity or security
instrument of the Company nor result in the acceleration of the due date of any
obligation of the Company; or

       

      (iv)         result
in the triggering of any piggy-back or other registration rights of any person
or entity holding securities of the Company or having the right to receive
securities of the Company.

       

      (g)          The Purchased Securities.  The
Purchased Securities upon issuance:

       

      (i)           are,
or will be, free and clear of any security interests, liens, claims or other
encumbrances, subject only to restrictions upon transfer under the 1933 Act and
any applicable state securities laws;

      

      (ii)          have
been, or will be, duly and validly authorized and on the date of issuance of the
Purchased Securities, the Purchased Securities will be duly and validly issued,
fully paid and nonassessable or if resold in a transaction registered pursuant
to the 1933 Act and pursuant to an effective registration statement or exempt
from registration will be free trading, unrestricted and
unlegended;

       

      (iii)         will
not have been issued or sold in violation of any preemptive or other similar
rights of the holders of any securities of the Company or rights to acquire
securities of the Company; and

       

      (iv)         will
not subject the holders thereof to personal liability by reason of being such
holders.

       

      (h)          Litigation.  There
is no pending or, to the best knowledge of the Company, threatened action, suit,
proceeding or investigation before any court, governmental agency or body, or
arbitrator having jurisdiction over the Company, or any of its Affiliates that
would affect the execution by the Company or the complete and timely performance
by the Company of its obligations under the Transaction
Documents.  Except as disclosed in the Reports, there is no pending
or, to the best knowledge of the Company, basis for or threatened action, suit,
proceeding or investigation before any court, governmental agency or body, or
arbitrator having jurisdiction over the Company, or any of its Affiliates which
litigation if adversely determined would have a Material Adverse
Effect.

      
        
           

        

        
          11

          
            

          

        

        
           

        

      

       

      (i)           
No Market
Manipulation.  The Company and its Affiliates have not taken,
and will not take, directly or indirectly, any action designed to, or that might
reasonably be expected to, cause or result in stabilization or manipulation of
the price of the common stock to facilitate the sale or resale of the
Purchased Securities or affect the price at which the Purchased Securities may
be issued or resold.

       

      (j)          
 Information
Concerning Company.  The Reports contain all material
information relating to the Company and its operations and financial condition
as of their respective dates which information is required to be disclosed
therein.   Since December 31, 2008 and except as modified in the
Reports or in the Schedules hereto, there has been no Material Adverse Effect
relating to the Company’s business, financial condition or affairs. The Reports,
including the financial statements included therein do not contain any untrue
statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein, taken as a whole,
not misleading in light of the circumstances and when made.

       

      (k)           Defaults.  The
Company is not in material violation of its articles of incorporation or
bylaws.   The Company is (i) not in default under or in violation
of any other material agreement or instrument to which it is a party or by which
it or any of its properties are bound or affected, which default or violation
would have a Material Adverse Effect, (ii) not in default with respect to
any order of any court, arbitrator or governmental body or subject to or party
to any order of any court or governmental authority arising out of any action,
suit or proceeding under any statute or other law respecting antitrust,
monopoly, restraint of trade, unfair competition or similar matters which
default would have a Material Adverse Effect, or (iii) not in violation of any
statute, rule or regulation of any governmental authority which violation would
have a Material Adverse Effect.

       

      (l)
           No Integrated
Offering.   Neither the Company, nor any of its
Affiliates, nor any person acting on its or their behalf, has directly or
indirectly made any offers or sales of any security of the Company nor solicited
any offers to buy any security of the Company under circumstances that would
cause the offer of the Purchased Securities pursuant to this Agreement to be
integrated with prior offerings by the Company for purposes of the 1933 Act or
any applicable stockholder approval provisions, including, without limitation,
under the rules and regulations of the Bulletin Board.  No prior
offering will impair the exemptions relied upon in this Offering or the
Company’s ability to timely comply with its obligations
hereunder.  Neither the Company nor any of its Affiliates will
take any action or steps that would cause the offer or issuance of the Purchased
Securities to be integrated with other offerings which would impair the
exemptions relied upon in this Offering or the Company’s ability to timely
comply with its obligations hereunder.  The Company will not conduct
any offering other than the transactions contemplated hereby that may be
integrated with the offer or issuance of the Purchased Securities that would
impair the exemptions relied upon in this Offering or the Company’s ability to
timely comply with its obligations hereunder.

       

      (m)          No General
Solicitation.  Neither the Company, nor any of its Affiliates,
nor to its knowledge, any person acting on its or their behalf, has engaged in
any form of general solicitation or general advertising (within the meaning of
Regulation D/Regulation S under the 1933 Act) in connection with the offer or
sale of the Purchased Securities.

      
        
           

        

        
          12

          
            

          

        

        
           

        

      

       

      (n)           No Undisclosed
Liabilities.  Since December 31, 2008, except as disclosed in
the Reports, the Company has no liabilities or obligations which are material,
individually or in the aggregate, other than those incurred in the ordinary
course of the Company businesses since December 31, 2008 and which, individually
or in the aggregate, would reasonably be expected to have a Material Adverse
Effect, except as disclosed in the Reports or on Schedule 4(n).

       

      (o)           No Undisclosed Events or
Circumstances.  Since December 31, 2008, except as disclosed in
the Reports, no event or circumstance has occurred or exists with respect to the
Company or its businesses, properties, operations or financial condition, that,
under applicable law, rule or regulation, requires public disclosure or
announcement prior to the date hereof by the Company but which has not been
so publicly announced or disclosed in the Reports.

       

      (p)           Dilution.   The
Company’s executive officers and directors understand the nature of the
Purchased Securities being sold hereby and recognize that the issuance of the
Purchased Securities will have a potential dilutive effect on the equity
holdings of other holders of the Company’s equity or rights to receive equity of
the Company.  The board of directors of the Company has concluded, in
its good faith business judgment that the issuance of the Purchased Securities
is in the best interests of the Company.  The Company specifically
acknowledges that its obligation to issue the Purchased Securities is binding
upon the Company and enforceable regardless of the dilution such issuance may
have on the ownership interests of other shareholders of the Company or parties
entitled to receive equity of the Company.

       

      (q)           No Disagreements with
Accountants and Lawyers. There are no disagreements of any kind
presently existing, or reasonably anticipated by the Company to arise between
the Company and the accountants and lawyers previously and presently employed by
the Company, including but not limited to disputes or conflicts over payment
owed to such accountants and lawyers, nor have there been any such disagreements
during the two years prior to the Closing Date, in each case, that could cause a
Material Adverse Effect.

      

      (r)
           Foreign Corrupt
Practices.  Neither the Company, nor to the knowledge of the
Company, any agent or other person acting on behalf of the Company, has (i)
directly or indirectly, used any funds for unlawful contributions, gifts,
entertainment or other unlawful expenses related to foreign or domestic
political activity, (ii) made any unlawful payment to foreign or domestic
government officials or employees or to any foreign or domestic political
parties or campaigns from corporate funds, (iii) failed to disclose fully any
contribution made by the Company (or made by any person acting on its behalf of
which the Company is aware) which is  in violation of law, or (iv)
violated in any material respect any provision of the Foreign Corrupt Practices
Act of 1977, as amended.

      

      (s)           Reporting
Company.  The Company is a publicly-held company subject to
reporting obligations pursuant to Section 13 of the Securities Exchange Act of
1934, as amended (the “1934
Act”).  Pursuant to the provisions of the 1934 Act, the Company
has timely filed all reports and other materials required to be filed thereunder
with the Commission during the preceding twelve months.

      
        
           

        

        
          13

          
            

          

        

        
           

        

      

      

      (t)
           Listing.  The
Company’s common stock is quoted on the Bulletin Board currently under the
symbol “WKBT”.  The Company has not received any oral or written
notice that its common stock is not eligible nor will become ineligible for
quotation on the Bulletin Board nor that its common stock does not meet all
requirements for the continuation of such quotation.  The Company
satisfies all the requirements for the continued quotation of its common stock
on the Bulletin Board.

      

      (u)           Transfer
Agent.   The name, address, telephone number, fax number,
contact person and email address of the Company transfer agent is set forth on
Schedule 4(u)
hereto.

      

      (v)           Environmental
Compliance. Since their inception, neither the Company, nor any of its
Subsidiaries have been, in violation of any applicable law relating to the
environment or occupational health and safety, where such violation would have a
Material Adverse Effect. The Company and its Subsidiaries (i) are in compliance
with any and all Environmental Laws (as hereinafter defined), (ii) have received
all permits, licenses or other approvals required of them under applicable
Environmental Laws to conduct their respective businesses and (iii) are in
compliance with all terms and conditions of any such permit, license or
approval where, in each of the foregoing clauses (i), (ii) and (iii), the
failure to so comply could be reasonably expected to have, individually or in
the aggregate, a Material Adverse Effect. “Environmental Laws” shall mean
all applicable laws relating to the protection of the environment including,
without limitation, all requirements pertaining to reporting, licensing,
permitting, controlling, investigating or remediating emissions, discharges,
releases or threatened releases of hazardous substances, chemical substances,
pollutants, contaminants or toxic substances, materials or wastes, whether
solid, liquid or gaseous in nature, into the air, surface water, groundwater or
land, or relating to the manufacture, processing, distribution, use, treatment,
storage, disposal, transport or handling of hazardous substances, chemical
substances, pollutants, contaminants or toxic substances, material or wastes,
whether solid, liquid or gaseous in nature. Other than as disclosed on Schedule 4(v), the Company and each of its
Subsidiaries are also in compliance with all other limitations, restrictions,
conditions, standards, requirements, schedules and timetables required or
imposed under all Environmental Laws. There are no past or present events,
conditions, circumstances, incidents, actions or omissions relating to or in any
way affecting the Company or its Subsidiaries that violate or may violate any
Environmental Law after the Closing Date or that may give rise to any
environmental liability, or otherwise form the basis of any claim, action,
demand, suit, proceeding, hearing, study or investigation (i) under any
Environmental Law, or (ii) based on or related to the manufacture, processing,
distribution, use, treatment, storage (including without limitation underground
storage tanks), disposal, transport or handling, or the emission, discharge,
release or threatened release of any hazardous substance where, in each of the
foregoing clauses (i) and (ii), the failure to so comply could be reasonably
expected to have, individually or in the aggregate, a Material Adverse
Effect.

      
        
           

        

        
          14

          
            

          

        

        
           

        

      

      

      (w)          Employees. Neither
the Company nor any Subsidiary has any collective bargaining arrangements or
agreements covering any of its employees. Except as disclosed in the Reports or
Other Written Information, neither the Company nor any Subsidiary has any
employment contract, agreement regarding proprietary information,
non-competition agreement, non-solicitation agreement, confidentiality
agreement, or any other similar contract or restrictive covenant, relating to
the right of any officer, employee or consultant to be employed or engaged by
the Company or such Subsidiary required to be disclosed with the Commission or
on the Form 8-K that is not so disclosed. Since December 31, 2008, no officer,
consultant or key employee of the Company or any Subsidiary whose termination,
either individually or in the aggregate, would have a Material Adverse Effect,
has terminated or, to the knowledge of the Company, has any present intention of
terminating his or her employment or engagement with the Company or any
Subsidiary.

      

      (x)           Public Utility Holding
Company Act; Investment Company Act and U.S. Real Property Holding Corporation
Status. The Company is not a “holding company” or a “public utility
company” as such terms are defined in the Public Utility Holding Company Act of
1935, as amended. The Company is not, and as a result of and immediately upon
the Closing will not be, an “investment company” or a company “controlled” by an
“investment company,” within the meaning of the Investment Company Act of
1940, as amended.  The Company is not and has never been a U.S. real
property holding corporation within the meaning of Section 897 of the Internal
Revenue Code of 1986, as amended.

      

      (y)           ERISA. No liability
to the Pension Benefit Guaranty Corporation has been incurred with respect to
any Plan (as defined below) by the Company or any of its Subsidiaries which is
or would be materially adverse to the Company and its subsidiaries. The
execution and delivery of this Agreement and the other Transaction Documents and
the issuance and sale of the Purchased Securities will not involve any
transaction which is subject to the prohibitions of Section 406 of ERISA or in
connection with which a tax could be imposed pursuant to Section 4975 of the
Internal Revenue Code of 1986, as amended, provided, that, if any of the
Subscribers, or any person or entity that owns a beneficial interest in any of
the Subscribers, is an “employee pension benefit plan” (within the meaning of
Section 3(2) of ERISA) with respect to which the Company is a “party in
interest” (within the meaning of Section 3(14) of ERISA), the requirements of
Sections 407(d)(5) and 408(e) of ERISA, if applicable, are met. As used in this
Section 2.1(bb), the term “Plan” shall mean an “employee
pension benefit plan” (as defined in Section 3 of ERISA) which is or has been
established or maintained, or to which contributions are or have been made, by
the Company or any Subsidiary or by any trade or business, whether or not
incorporated, which, together with the Company or any Subsidiary, is under
common control, as described in Section 414(b) or (c) of the
Code.

      
        
           

        

        
          15

          
            

          

        

        
           

        

      

      

      (z)           Independent Nature of
Subscribers. The Company acknowledges that the obligations of each
Subscriber under the Transaction Documents are several and not joint with the
obligations of any other Subscriber, and no Subscriber shall be responsible in
any way for the performance of the obligations of any other Subscriber under the
Transaction Documents. The Company acknowledges that the decision of each
Subscriber to purchase securities pursuant to this Agreement has been made by
such Subscriber independently of any other Subscriber and independently of any
information, materials, statements or opinions as to the business, affairs,
operations, assets, properties, liabilities, results of operations, condition
(financial or otherwise) or prospects of the Company or of its Subsidiaries
which may have been made or given by any other Subscriber or by any agent or
employee of any other Subscriber, and no Subscriber or any of its agents or
employees shall have any liability to any Subscriber (or any other person)
relating to or arising from any such information, materials, statements or
opinions. The Company acknowledges that nothing contained herein, or in any
Transaction Documents, and no action taken by any Subscriber pursuant hereto or
thereto, shall be deemed to constitute the Subscribers as a partnership, an
association, a joint venture or any other kind of entity, or create a
presumption that the Subscribers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the
Transaction Documents. The Company acknowledges that each Subscriber shall be
entitled to independently protect and enforce its rights, including without
limitation, the rights arising out of this Agreement or out of the other
Transaction Documents, and it shall not be necessary for any other Subscriber to
be joined as an additional party in any proceeding for such
purpose.

      

      (aa)         Sarbanes-Oxley Act.
The Company is in material compliance with the applicable provisions of the
Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), and the
rules and regulations promulgated thereunder, that are effective and for which
material compliance by the Company is required as of the date
hereof.

      

      (bb)        PFIC.  Neither
the Company nor any of its Subsidiaries is or intends to become a “passive
foreign investment company” within the meaning of Section 1297 of the U.S.
Internal Revenue Code of 1986, as amended.

      

      (cc)         OFAC. Neither the
Company nor any of its Subsidiaries nor, to the knowledge of the Company, any
director, officer, agent, employee, Affiliate or person acting on behalf of any
of the Company or any of its Subsidiaries, is currently subject to any U.S.
sanctions administered by the Office of Foreign Assets Control of the U.S.
Treasury Department (“OFAC”); and the Company will
not directly or indirectly use the proceeds of the sale of the Purchased
Securities, or lend, contribute or otherwise make available such proceeds to any
subsidiary of the Company, joint venture partner or other person or entity,
towards any sales or operations in Cuba, Iran, Syria, Sudan, Myanmar or any
other country sanctioned by OFAC or for the purpose of financing the activities
of any person currently subject to any U.S. sanctions administered by
OFAC.

      

      (dd)        Money Laundering
Laws. The operations of each of the Company and its Subsidiaries are and
have been conducted at all times in compliance with the money laundering
requirements of all applicable governmental authorities and any related or
similar rules, regulations or guidelines, issued, administered or enforced by
any governmental authority (collectively, the “Money Laundering Laws”) and no action, suit or
proceeding by or before any court or governmental authority or any arbitrator
involving any of the Company or any of its Subsidiaries with respect to the
Money Laundering Laws is pending or, to the best knowledge of the Company,
threatened.

      
        
           

        

        
          16

          
            

          

        

        
           

        

      

      

      (ee)         Company Predecessor and
Subsidiaries.  The Company makes each of the representations
contained in Sections 4(a), (b), (c), (d), (e), (f), (h), (j), (k), (l), (m),
(n), (o), (p), (q), (r), (v), (w), (y), (aa), (bb), (cc) and (dd) of this
Agreement, as same relate or could be applicable to each
Subsidiary.  All representations made by or relating to the Company of
a historical or prospective nature and all undertakings described in Sections
7(f) through 7(l) shall relate, apply and refer to the Company and its
predecessors and successors.  The Company represents that it owns all
of the equity of the Subsidiaries and rights to receive equity of the
Subsidiaries identified on Schedule 4(a), free and clear of all
liens, encumbrances and claims, except as set forth on Schedule 4(a).  The Company
further represents that except as described in the Reports the Subsidiaries have
not been known by any other name for the prior five years.

      

      (ff)          Solvency. Based on
the financial condition of the Company as of the Closing Date after giving
effect to the receipt by the Company of the proceeds from the Offering (i) the
Company’s fair saleable value of its assets exceeds the amount that will be
required to be paid on or in respect of the Company’s existing debts and other
liabilities (including known contingent liabilities) as they mature; (ii) the
Company’s assets do not constitute unreasonably small capital to carry on its
business for the current fiscal year as now conducted and as proposed to be
conducted including its capital needs taking into account the particular capital
requirements of the business conducted by the Company, and projected capital
requirements and capital availability thereof; and (iii) the current cash flow
of the Company, together with the proceeds the Company would receive, were it to
liquidate all of its assets, after taking into account all anticipated uses of
the cash, would be sufficient to pay all amounts on or in respect of its debt
when such amounts are required to be paid. The Company does not intend to incur
debts beyond its ability to pay such debts as they mature (taking into account
the timing and amounts of cash to be payable on or in respect of its
debt).

      

      (gg)        Correctness of
Representations.  The Company represents that the foregoing
representations and warranties are true and correct as of the date hereof in all
material respects, and, unless the Company otherwise notifies the Subscribers
prior to the Closing Date, shall be true and correct in all material respects as
of the Closing Date; provided, that, if such representation or warranty is made
as of a different date, in which case such representation or warranty shall be
true as of such date.

       

      (hh)        Survival.  The
foregoing representations and warranties shall survive for a period of two years
after the Closing Date.

       

      (ii)          No
Brokers.  Neither the Company nor any Subsidiary has taken any
action which would give rise to any claim by any person for brokerage
commissions, finder’s fees or similar payments relating to this Agreement or the
transactions contemplated hereby, except for dealings with the Placement Agent,
whose commissions and fees will be paid by the Company and except as set forth
on Schedule
4(ii).

       

      5.           Regulation D/Regulation S Offering/Legal
Opinion.  The offer and issuance of the Purchased Securities to
the Subscribers is being made pursuant to the exemption from the registration
provisions of the 1933 Act afforded by Section 4(2) or Section 4(6) of the 1933
Act or Rule 506 of Regulation D and/or Regulation S promulgated
thereunder.  On the Closing Date, the Company will provide an opinion
reasonably acceptable to the Subscribers from the Company’s legal counsel
opining on the availability of an exemption from registration under the 1933 Act
as it relates to the offer and issuance of the Purchased
Securities.  A form of the Closing Legal Opinion is annexed hereto as
Exhibit D.  The Company will
provide, at the Company’s expense, such other legal opinions, if any, as are
reasonably necessary in each Subscriber’s opinion for the issuance and resale of
the Purchased Securities pursuant to an effective registration
statement. The Company shall approve, or have its designated counsel
approve, Rule 144 legal opinion requests from Subscriber’s counsel for removal
of restrictive legends to the Purchased Securities, within three (3) business
days of such request being provided to the Company’s transfer
agent.

      
        
           

        

        
          17

          
            

          

        

        
           

        

      

       

      6.           Legal
Fees.   The Company shall pay a fee of $23,000 to Anslow
& Jaclin, LLP, as reimbursement for legal services rendered to the
Subscriber in connection with this Agreement and the purchase and sale of
the Offering, and $2,000 to Spectrum-OSO Asia Limited for due diligence
related services.   The $25,000 fee for Subscriber’s legal fees
and expenses (to the extent known as of the Closing) will be payable out of
funds held pursuant to the Escrow Agreement and paid at Closing.

       

      7.           Covenants of the
Company.  The Company covenants and agrees with the Subscribers
as follows:

       

      (a)           Stop
Orders.  Subject to the prior notice requirement described in
Section 7(n), the Company will advise the Subscribers, within twenty-four hours
after it receives notice of issuance by the Commission, any state securities
commission or any other regulatory authority of any stop order or of any order
preventing or suspending any offering of any securities of the Company, or of
the suspension of the qualification of the common stock of the Company for
offering or sale in any jurisdiction, or the initiation of any proceeding for
any such purpose.  The Company will not issue any stop transfer order
or other order impeding the sale, resale or delivery of any of the Purchased
Securities, except as may be required by any applicable federal or state
securities laws and unless contemporaneous notice of such instruction is given
to the Subscribers.

       

      (b)           Listing/Quotation.  The
Company will maintain the quotation or listing of its common stock on the
American Stock Exchange, Nasdaq Capital Market, Nasdaq Global Market, Nasdaq
Global Select Market, Bulletin Board, or New York Stock Exchange (whichever of
the foregoing is at the time the principal trading exchange or market for the
common stock (the “Principal
Market”), and will comply in all respects with the Company’s reporting,
filing and other obligations under the bylaws or rules of the Principal Market,
as applicable, as long as any Purchased Securities are outstanding. The Company
will provide Subscribers with copies of all notices it receives notifying the
Company of the threatened and actual delisting of the common stock from any
Principal Market.  As of the date of this Agreement and the Closing
Date, the Bulletin Board is and will be the Principal Market.

       

      (c)           Market
Regulations.  If required, the Company shall notify the
Commission, the Principal Market and applicable state authorities, in accordance
with their requirements, of the transactions contemplated by this Agreement, and
shall take all other necessary action and proceedings as may be required and
permitted by applicable law, rule and regulation, for the legal and valid
issuance of the Purchased Securities to the Subscribers and promptly provide
copies thereof to the Subscribers.

      
        
           

        

        
          18

          
            

          

        

        
           

        

      

       

      (d)           Filing
Requirements.  From the date of this Agreement and until the
last to occur of (i) one (1) year after the Final Closing Date, or (ii) until
the Purchased Securities can be resold or transferred by the Subscribers
pursuant to Rule 144(b)(1)(i) (the date of such latest occurrence being the
“End Date”), the Company
will (A) comply in all respects with its reporting and filing obligations under
the 1934 Act, and (B) comply with all requirements related to any registration
statement filed pursuant to this Agreement.  The Company will use its
best efforts not to take any action or file any document (whether or not
permitted by the 1933 Act or the 1934 Act or the rules thereunder) to terminate
or suspend such registration or to terminate or suspend its reporting and filing
obligations under said acts until the End Date.  Until the End Date,
the Company will continue the listing or quotation of the common stock on a
Principal Market and will comply in all respects with the Company’s reporting,
filing and other obligations under the bylaws or rules of the Principal
Market.  The Company agrees to timely file a Form D with respect to
the Purchased Securities if required under Regulation D and to provide a copy
thereof to each Subscriber promptly after such filing.

       

      (e)           Use of
Proceeds.   The proceeds of the Offering will be employed
by the Company for expenses of the Offering, and general working
capital.  Except as described on Schedule 7(e), the Purchase
Price may not and will not be used for accrued and unpaid officer and director
salaries, payment of financing related debt, redemption of outstanding notes or
equity instruments of the Company nor non-trade obligations outstanding on the
Closing Date.

       

      (f)           DTC
Program.  If the Company is eligible for DTC's "FAST"
program, it will, for a period of at least two (2) years from the Final Closing
Date, use its best efforts to employ as the transfer agent for the Purchased
Securities a participant in the Depository Trust Company Automated Securities
Transfer Program that is eligible to deliver shares via the Deposit Withdrawal
Agent Commission System.

       

      (g)           Taxes.  From
the date of this Agreement and until the End Date, the Company will promptly pay
and discharge, or cause to be paid and discharged, when due and payable, all
lawful taxes, assessments and governmental charges or levies imposed upon the
income, profits, property or business of the Company; provided, however, that
any such tax, assessment, charge or levy need not be paid if the validity
thereof shall currently be contested in good faith by appropriate proceedings
and if the Company shall have set aside on its books adequate reserves with
respect thereto, and provided, further, that the Company will pay all such
taxes, assessments, charges or levies forthwith upon the commencement of
proceedings to foreclose any lien which may have attached as security
therefore.

       

      (h)           Insurance.  As
reasonably necessary as determined by the Company, from the date of this
Agreement and until the End Date, the Company will keep its assets which are of
an insurable character insured by financially sound and reputable insurers
against loss or damage by fire, explosion and other risks customarily insured
against by companies in the Company’s line of business and location, in amounts
and to the extent and in the manner customary for companies in similar
businesses similarly situated and located and to the extent available on
commercially reasonable terms.

       

      (i)
           Books and
Records.  From the date of this Agreement and until the End
Date, the Company will keep true records and books of account in which full,
true and correct entries will be made of all dealings or transactions in
relation to its business and affairs in accordance with generally accepted
accounting principles applied on a consistent basis.

      
        
           

        

        
          19

          
            

          

        

        
           

        

      

    

    (j)           Governmental
Authorities.   From the date of this Agreement and until
the End Date, the Company shall duly observe and conform in all material
respects to all valid requirements of governmental authorities relating to the
conduct of its business or to its properties or assets.

     

    (k)           Intellectual
Property.  From the date of this Agreement and until the End
Date, the Company shall maintain in full force and effect its corporate
existence, rights and franchises and all licenses and other rights to use
intellectual property owned or possessed by it and reasonably deemed to be
necessary to the conduct of its business, unless it is sold for
value.  Schedule
7(k) hereto identifies all of
the intellectual property owned by the Company and Subsidiaries.

     

    (l)           Properties.  From
the date of this Agreement and until the End Date, the Company will keep its
properties in good repair, working order and condition, reasonable wear and tear
excepted, and from time to time make all necessary and proper repairs, renewals,
replacements, additions and improvements thereto; and the Company will at all
times comply with each provision of all leases and claims to which it is a party
or under which it occupies or has rights to property if the breach of such
provision could reasonably be expected to have a Material Adverse
Effect.  The Company will not abandon any of its assets except for
those assets which have negligible or marginal value or for which it is prudent
to do so under the circumstances.

     

     (m)         Confidentiality/Public
Announcement.   From the date of this Agreement and until
the End Date, the Company agrees that except in connection with a Form 8-K and
the registration statement or statements regarding the Subscriber’s Purchased
Securities or in correspondence with the SEC regarding same, it will not
disclose publicly or privately the identity of the Subscriber unless expressly
agreed to in writing by a Subscriber or only to the extent required by law and
then only upon not less than three days prior notice to
Subscriber.  In any event and subject to the foregoing, the Company
undertakes to file a Form 8-K and issue a press release describing the Offering
on the fourth business day after the Closing Date.  Prior to the
Closing Date, such Form 8-K will be provided to Subscribers for their review and
approval.  In the Form 8-K, the Company will specifically disclose the
nature of the Offering and amount of common stock outstanding immediately after
the Closing.  Upon  delivery by the Company to the
Subscribers after the Closing Date of any notice or information, in writing,
electronically or otherwise, and while the Purchased Securities are held by
Subscribers, unless the  Company has in good faith determined that the
matters relating to such notice do not constitute material, nonpublic
information relating to the Company or
Subsidiaries, the Company  shall within four business days after
any such delivery publicly disclose such  material,  nonpublic 
information on a Report on Form 8-K, provided, however, that
the Company will have no obligation to file any Report on Form 8-K with respect
to (i) any information contained in the registration statement relating to the
registration of the Registrable Securities, submitted for investors’ review
pursuant to Section 9 herein, and (ii) the information as to currently
contemplated and/or negotiated financing transactions.  In
the event that the Company believes that a
notice or communication to Subscribers contains material, nonpublic
information relating to the Company or Subsidiaries, the Company shall so
indicate to Subscribers prior to delivery of such notice or
information.  Subscribers will be granted sufficient time to notify
the Company that such Subscriber elects not to receive such
information.   In such case, the Company will not deliver such
information to Subscribers.  In the absence of any such
indication, Subscribers shall be allowed to presume that all matters
relating to such notice and information do not constitute material,
nonpublic information relating to the Company or Subsidiaries.

    
      
         

      

      
        20

        
          

        

      

      
         

      

    

     

    (n)           Non-Public
Information.  The Company covenants and agrees that except for
the Reports, Other Written Information and schedules and exhibits to this
Agreement and the Transaction Documents, which information the Company
undertakes to publicly disclose on the Form 8-K described in Section 7(m) above
and except for the information as to currently contemplated and/or negotiated
financing transactions, neither it nor any other person acting on its behalf
will at any time provide any Subscriber or its agents or counsel with any
information that the Company believes constitutes material non-public
information, unless prior thereto such Subscriber shall have agreed in writing
to accept such information.  The Company understands and confirms that
each Subscriber shall be relying on the foregoing representations in
effecting transactions in securities of the Company.

     

    (o)           Reserved.                      

     

    (p)           Lockup
Agreement.   The Company will deliver to the Subscribers
on or before the Closing Date, and enforce the provisions of, irrevocable lockup
agreements (“Lockup
Agreement”) in the form annexed hereto as Exhibit C, with the persons identified
on Schedule 7(p).

     

    (q)           Board of Directors.
 As soon as possible, but no later than one hundred twenty (120) days after
the Closing Date (the “Uplisting Board Date”), the
Company shall comply with all Nasdaq Corporate Governance standards, including,
but not limited to, appointment of a number of independent directors to exceed
the number of non-independent directors on the board (the “Uplisting
Board”).

     

    (r)           Investor Relations
Escrow.  The Company shall cause to be deposited, pursuant to
the terms of the Investor Relations Escrow Agreement set forth in Exhibit B, One Hundred Fifty
Thousand Dollars ($150,000) of the Purchase Price of the initial Closing
(the “IR Escrow Funds”), in an escrow account
with Anslow & Jaclin, LLP to be used by the Company in connection with
investor relations services.  The IR Escrow Funds will be payable
pursuant to the Investor Relations Escrow Agreement. Opus Holdings will appoint
an individual (the “IR
Representative”) to act on behalf of the Company in designating the
disbursement of the IR Escrow Funds and the IR Shares to an investor relations
firm to be designated by Opus Holdings (the “Investor Relations Firm”). The
Company shall issue 180,000 shares of the Company’s common stock (the
“IR Shares”) at the
Initial Closing to be designated by the IR Representative for investor relations
services.  The Company shall issue an additional 20,000 IR Shares for
every additional One Million Two Hundred Fifty Thousand Dollars ($1,250,000)
raised in Subsequent Closings as designated by the IR
Representative.  In addition, the Company shall issue 600,000 shares
of common stock to Far East Strategies, LLC, and various other consultants or
their designees, for various investor relations and advisory services to be
provided to the Company.  The Company understands and hereby
acknowledges the existence of a prior relationship between the Subscribers and
Far East Strategies.

    
      
         

      

      
        21

        
          

        

      

      
         

      

    

    

    (s)           Investor Relations Firm. As
of the Closing Date, the Company shall retain the Investor Relations
Firm as the general contractor for the Company’s investor relations
services.

    

    (t)           Additional Negative
Covenants.  From the date of this Agreement until the earlier
of (i) six (6) months from the final Closing or (ii) the effective date of the
Registration Statement, the Company will not and will not permit any of its
Subsidiaries, without the written consent of the Subscribers, to directly or
indirectly:

    

    (i)           engage
in any business other than businesses engaged in or proposed to be engaged in by
the Company on the Closing Date or businesses similar thereto;

    

    (ii)         merge
or consolidate with any person or entity (other than mergers of wholly owned
subsidiaries into the Company), or sell, lease or otherwise dispose of its
assets other than in the ordinary course of business involving an aggregate
consideration of more than ten percent (10%) of the book value of its assets on
a consolidated basis in any 12-month period, or liquidate, dissolve,
recapitalize or reorganize;

    

    (iii)        incur
any indebtedness for borrowed money or become a guarantor or otherwise
contingently liable for any such indebtedness in excess of three million dollars
($3,000,000), except for obligations incurred in the ordinary course of
business;

    

    (iv)        enter
into any new agreement or make any amendment to any existing agreement, which by
its terms would restrict the Company’s performance of its obligations to holders
of the Purchased Securities pursuant to this Agreement or any Transaction
Documents;

    

    (v)         enter
into any agreement with any holder or prospective holder of any securities of
the Company providing for the granting to such holder of registration rights,
preemptive rights, special voting rights or protection against dilution;
or

    

    (vi)        during
the period ending two (2) years from the Initial Closing, re-pay principal,
interest or finance charges of any kind whatsoever on the related party debt of
approximately $7,700,000 (the “Related Party Debt”) listed on
the Company’s financial statements for the quarter ended September 30, 2009, and
do hereby guarantee that the related party holders of such debt shall not
initiate any actions of default, foreclosure or other form of enforcement
arising from the Related Party Debt.

    

    (u)           The
Company will prior to May 31, 2010 either (i) pay the RMB 57 million owed to
Parties B and C as set forth in the Equity Interest Transfer Agreement dated
October 25, 2007, or (ii) obtain an extension of the payment date from the local
approval authority in the PRC.  The Company shall retain AllBright Law
Offices as its PRC counsel in connection therewith.

    
      
         

      

      
        22

        
          

        

      

      
         

      

    

     

    8.           Covenants of the Company
Regarding Indemnification.

     

    (a)           The
Company agrees to indemnify, hold harmless, reimburse and defend the
Subscribers, the Subscribers’ officers, directors, agents, Affiliates, members,
managers, control persons, and principal shareholders, against any claim, cost,
expense, liability, obligation, loss or damage (including reasonable legal fees)
of any nature, incurred by or imposed upon the Subscribers or any such person
which results, arises out of or is based upon (i) any material misrepresentation
by the Company or breach of any representation or warranty by the Company in
this Agreement or in any Exhibits or Schedules attached hereto in any
Transaction Documents, or (ii) after any applicable notice and/or cure periods,
any breach or default in performance by the Company of any material covenant or
undertaking to be performed by the Company hereunder, or any other material
agreement entered into by the Company and Subscribers relating
hereto.

     

    (b)           The
Subscribers agree to indemnify, hold harmless, reimburse and defend
the Company, the Company’s officers, directors, agents, Affiliates,
members, managers, control persons, and principal shareholders, against any
claim, cost, expense, liability, obligation, loss or damage (including
reasonable legal fees) of any nature, incurred by or imposed upon them or any
such person which results, arises out of or is based upon any material
misrepresentation by the Subscribers in this Agreement or in any Exhibits or
Schedules attached hereto or in any Transaction
Documents.  Notwithstanding the forgoing, in no event shall the
liability of the Subscriber or permitted successor hereunder, or under any
Transaction Documents or other agreement delivered in connection
herewith, exceed the Purchase Price paid by such Subscriber.

     

    (c)           The
procedures set forth in Section 9(f) shall apply to the indemnification set
forth in Section 8.

    
      
         

      

      
        23

        
          

        

      

      
         

      

    

    9.           Registration
Rights.

     

    (a)           Registration Statement
Requirements.  The Company shall file with the Commission a
Form S-1 registration statement (the “Registration Statement”) (or
such other form that it is eligible to use) in order to register all or such
portion of the Registrable Shares as permitted by the Commission (provided that
the Company shall use diligent efforts to advocate with the Commission for the
registration of all of the Registrable Shares) pursuant to Rule 415 for resale
and distribution under the 1933 Act on or before the date (the “Required Filing Date”) which
is forty five (45) calendar days after the Final Closing Date, and use its best
efforts to cause the Registration Statement to be declared effective by the date
(the “Required Effective
Date”) which is not later than the earlier of (x) one hundred twenty
(120) calendar days after the Final Closing Date, or (y) three (3) business days
after oral or written notice to the Company or its counsel from the Commission
that it may be declared effective. The Company will register not less than 100%
of the Purchased Shares and the Warrant Shares in the aforedescribed
Registration Statement (the “Registrable
Shares”).  In the event that the Company is required by the
Commission to cutback the number of shares being registered in the Registration
Statement pursuant to Rule 415, then the Company shall reduce the Registrable
Shares pro rata, and unless otherwise directed in writing by the Subscriber as
to its Registrable Shares, the number of Registrable Shares to be registered on
such Registration Statement will first be reduced by Registrable Shares
represented by Warrant Shares and second by Registrable Shares represented by
Purchased Shares.  The Registration Statement shall also state that,
in accordance with Rules 416 and 457 under the 1933 Act, it also covers such
indeterminate number of additional shares of common stock as may become issuable
with respect to the Registrable Shares to prevent dilution resulting from stock
splits, stock dividends or similar transactions. Notwithstanding anything to the
contrary contained in this Section 9, if the Company receives Commission
Comments, and following discussions with and responses to the Commission in
which the Company uses its reasonable best efforts and time to cause as many
Registrable Shares for as many Subscribers as possible to be included in the
Registration Statement filed pursuant to Section 9(a) without characterizing any
Subscriber as an underwriter, the Company is unable to cause the inclusion of
all Registrable Shares in such Registration Statement, then the Company may,
following not less than three (3) Trading Days prior written notice to the
Subscribers, (x) remove from the Registration Statement such Registrable Shares
(the “Cut Back Shares”)
and/or (y) agree to such restrictions and limitations on the registration and
resale of the Registrable Shares, in each case as the Commission may require in
order for the Commission to allow such Registration Statement to become
effective; provided, that in no
event may the Company name any Subscriber as an underwriter without such
Subscriber’s prior written consent (collectively, the “Commission Restrictions”).
Unless the Commission Restrictions otherwise require, any cut-back imposed
pursuant to this Section 9(a) shall be allocated among the Registrable Shares of
the Subscribers on a pro rata basis. No liquidated damages under Section 9(d)
shall accrue on or as to any Cut Back Shares, and the required Commission
Effectiveness Date for such additional Registration Statement including the
Cutback Shares will be tolled, until such time as the Company is able to effect
the registration of the Cut Back Shares in accordance with any Commission
Restrictions (such date, the “Restriction Termination
Date”). From and after the Restriction Termination Date, all provisions
of this Section 9 (including, without limitation, the liquidated damages
provisions, subject to tolling as provided above) shall again be applicable to
the Cut Back Shares (which, for avoidance of doubt, retain their character as
“Registrable Shares”) so that the Company will be required to file with and
cause to be declared effective by the Commission such additional Registration
Statements in the time frames set forth herein as necessary to ultimately cause
to be covered by effective Registration Statements all Registrable Shares (if
such Registrable Shares cannot at such time be resold by the Subscribers thereof
pursuant to Rule 144).

     

    (b)           Registration
Procedures. If and
whenever the Company is required by the provisions of Section 9(a) to effect the
registration of any Registrable Shares under the 1933 Act, the Company will, as
expeditiously as possible:

     

    (i)           subject
to the timelines provided in this Agreement, prepare and file with the
Commission a registration statement required by Section 9, with respect to such
securities and use its best commercially reasonable efforts to cause such
registration statement to become and remain effective for the period of the
distribution contemplated thereby (determined as herein provided), and promptly
provide to Subscriber’s Counsel copies of all filings and Commission letters of
comment and notify the Subscribers (by telecopier and by e-mail addresses
provided by the Subscribers) and Subscriber’s Counsel (by telecopier and by
email to ktrauger@anslowlaw.com) on or
before the second  business day thereafter that the Company receives
notice that (i) the Commission has no comments or no further comments on the
registration statement, and (ii) the registration statement has been declared
effective;

    
      
         

      

      
        24

        
          

        

      

      
         

      

    

     

    (ii)          prepare
and file with the Commission such amendments and supplements to such
registration statement and the prospectus used in connection therewith as may be
necessary to keep such registration statement effective until such registration
statement has been effective for the later of (a) a period of one (1) year, or
(b) until the Purchased Securities can been sold by the Subscribers
pursuant to Rule 144 without volume restrictions;

     

    (iii)         furnish
to the Subscribers such number of copies of the registration statement and
the prospectus included therein (including each preliminary prospectus) as such
Subscribers reasonably may request in order to facilitate the public sale or
their disposition of the securities covered by such registration statement or
make them electronically available;

     

    (iv)         use
its reasonable best efforts to register or qualify the Registrable Shares
covered by such registration statement under the securities or “blue sky” laws
of such jurisdictions as the Subscribers shall request in writing, provided,
however, that the Company shall not for any such purpose be required to qualify
to transact business as a foreign corporation in any jurisdiction where it is
not so qualified or to consent to service of process in any such
jurisdiction;

     

    (v)         list
the Registrable Shares covered by such registration statement with any
securities exchange on which the common stock of the Company is then
listed;

     

    (vi)        notify
the Subscribers within twenty-four hours of the Company’s becoming aware that a
prospectus relating thereto is required to be delivered under the 1933 Act, of
the happening of any event of which the Company has knowledge as a result of
which the prospectus contained in such registration statement, as then in
effect, includes an untrue statement of a material fact or omits to state a
material fact required to be stated therein or necessary to make the statements
therein not misleading in light of the circumstances then existing or which
becomes subject to a Commission, state or other governmental order suspending
the effectiveness of the registration statement covering any of the Registrable
Shares. Each Subscriber hereby covenants that it will not sell any Registrable
Shares pursuant to such prospectus during the period commencing at the time at
which the Company gives such Subscriber notice of the suspension of the use of
such prospectus in accordance with this Section 9(b)(vi) and ending at the time
the Company gives such Subscriber notice that such Subscriber may thereafter
effect sales pursuant to the prospectus, or until the Company delivers to such
Subscriber or files with the Commission an amended or supplemented
prospectus.

     

    (c)           Provision of
Documents.  It shall be a condition precedent to the
obligations of the Company to complete the registration pursuant to this
Agreement with respect to the Registrable Shares of a
particular Subscriber that such Subscriber shall furnish to the
Company in writing such information and representation letters, including a
completed form of the Selling Securityholder Questionnaire attached as Exhibit E hereto, with respect to
itself and the proposed distribution by it as the Company may reasonably request
to assure compliance with federal and applicable state securities
laws.

    
      
         

      

      
        25

        
          

        

      

      
         

      

    

     

    (d)           Non-Registration
Events.  The Company and the Subscribers agree that the
Subscribers will suffer damages if the Registration Statement is not filed by
the Required Filing Date and not declared effective by the Commission by the
Required Effective Date or if, after it is declared effective, its effectiveness
is not maintained in the manner and within the time periods contemplated by
Section 9 hereof, and it would not be feasible to ascertain the extent of
such damages with precision.  Accordingly, if (A) the Registration
Statement is not filed on or before the Required Filing Date, (B) the
Registration Statement is not declared effective on or before the Required
Effective Date, or (C) any registration statement described in Section 9
declared effective but shall thereafter cease to be effective for a period of
time which shall exceed forty (40) days in the aggregate per year (defined as a
period of 365 days commencing on the date the Registration Statement is declared
effective) (each such event referred to in clauses A through C of this Section
9(d), a “Non-Registration
Event”), then the Company shall deliver to the Subscribers, as liquidated
damages (“Liquidated
Damages”), an amount equal to one-half percent (0.5%) of the Purchase
Price of the Purchased Shares owned of record by such holder on the first
business day after the Non-Registration Event and for each subsequent thirty
(30) day period (pro rata for any period less than thirty days) which are
subject to such Non-Registration Event. The maximum aggregate Liquidated Damages
payable to the Subscriber under this Agreement shall be nine percent (9%) of the
aggregate Purchase Price paid by the Subscriber pursuant to this
Agreement. The Company must pay the Liquidated Damages in cash. In the
event a Registration Statement is filed by the Required Filing Date but is
withdrawn prior to being declared effective by the Commission, then such
Registration Statement will be deemed to have not been filed.

     

    (e)           Expenses.  All
expenses incurred by the Company in complying with Section 9, including, without
limitation, all registration and filing fees, printing expenses (if required),
fees and disbursements of counsel and independent public accountants for the
Company, fees and expenses (including reasonable counsel fees) incurred in
connection with complying with state securities or “blue sky” laws, fees of the
FINRA, transfer taxes, and fees of transfer agents and registrars, are called
“Registration Expenses.”
The Company will pay all Registration Expenses in connection with any
registration statement described in Section 9.

     

    (f)           Indemnification and
Contribution.

     

    (i)           In
the event of a registration of any Registrable Shares under the 1933 Act
pursuant to Section 9, the Company will, to the extent permitted by law,
indemnify and hold harmless the Subscriber, each of the officers, directors,
agents, Affiliates, members, managers, control persons, and principal
shareholders of the Subscriber, each underwriter of such Registrable Shares
thereunder and each other person, if any, who controls such Subscriber or
underwriter within the meaning of the 1933 Act, against any losses, claims,
damages or liabilities, joint or several, to which the Subscriber, or such
underwriter or controlling person may become subject under the 1933 Act or
otherwise, insofar as such losses, claims, damages or liabilities (or actions in
respect thereof) arise out of or are based upon any untrue statement or alleged
untrue statement of any material fact contained in any registration statement
under which such Registrable Shares was registered under the 1933 Act pursuant
to Section 9, any preliminary prospectus or final prospectus contained therein,
or any amendment or supplement thereof, or arise out of or are based upon the
omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein not misleading in
light of the circumstances when made, and will subject to the provisions of
Section 9(f)(iii) reimburse the Subscriber, each such underwriter and each such
controlling person for any legal or other expenses reasonably incurred by them
in connection with investigating or defending any such loss, claim, damage,
liability or action; provided, however, that the Company shall not be liable to
the Subscriber to the extent that any such damages arise out of or are based
upon an untrue statement or omission made in any preliminary prospectus if (i)
the Subscriber failed to send or deliver a copy of the final prospectus
delivered by the Company to the Subscriber with or prior to the delivery of
written confirmation of the sale by the Subscriber to the person asserting the
claim from which such damages arise, (ii) the final prospectus would have
corrected such untrue statement or alleged untrue statement or such omission or
alleged omission, or (iii) to the extent that any such loss, claim, damage or
liability arises out of or is based upon an untrue statement or alleged untrue
statement or omission or alleged omission so made in conformity with
information furnished by any such Subscriber in writing specifically for use in
such registration statement or prospectus.

    
      
         

      

      
        26

        
          

        

      

      
         

      

    

     

    (ii)          In
the event of a registration of any of the Registrable Shares under the 1933 Act
pursuant to Section 9, each Subscriber severally but not jointly will, to the
extent permitted by law, indemnify and hold harmless the Company, and each
person, if any, who controls the Company within the meaning of the 1933 Act,
each officer of the Company who signs the registration statement, each director
of the Company, each underwriter and each person who controls any underwriter
within the meaning of the 1933 Act, against all losses, claims, damages or
liabilities, joint or several, to which the Company or such officer, director,
underwriter or controlling person may become subject under the 1933 Act or
otherwise, insofar as such losses, claims, damages or liabilities (or actions in
respect thereof) arise out of or are based upon any untrue statement or alleged
untrue statement of any material fact contained in the registration statement
under which such Registrable Shares were registered under the 1933 Act pursuant
to Section 9, any preliminary prospectus or final prospectus contained therein,
or any amendment or supplement thereof, or arise out of or are based upon the
omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein not misleading, and
will reimburse the Company and each such officer, director, underwriter and
controlling person for any legal or other expenses reasonably incurred by them
in connection with investigating or defending any such loss, claim, damage,
liability or action, provided, however, that the Subscriber will be liable
hereunder in any such case if and only to the extent that any such loss, claim,
damage or liability arises out of or is based upon an untrue statement or
alleged untrue statement or omission or alleged omission made in reliance upon
and in conformity with information pertaining to such Subscriber, as such,
furnished in writing to the Company by such Subscriber specifically for use in
such registration statement or prospectus, and provided, further, however, that
the liability of the Subscriber hereunder shall be limited to the net proceeds
actually received by the Subscriber from the sale of Registrable Shares pursuant
to such registration statement.

    
      
         

      

      
        27

        
          

        

      

      
         

      

    

     

    (iii)         Promptly
after receipt by an indemnified party hereunder of notice of the commencement of
any action, such indemnified party shall, if a claim in respect thereof is to be
made against the indemnifying party hereunder, notify the indemnifying party in
writing thereof, but the omission so to notify the indemnifying party shall not
relieve it from any liability which it may have to such indemnified party other
than under this Section 9(f)(iii) and shall only relieve it from any liability
which it may have to such indemnified party under this Section 9(f)(iii), except
and only if and to the extent the indemnifying party is prejudiced by such
omission. In case any such action shall be brought against any indemnified party
and it shall notify the indemnifying party of the commencement thereof, the
indemnifying party shall be entitled to participate in and, to the extent it
shall wish, to assume and undertake the defense thereof with counsel
satisfactory to such indemnified party, and, after notice from the indemnifying
party to such indemnified party of its election so to assume and undertake the
defense thereof, the indemnifying party shall not be liable to such indemnified
party under this Section 9(f)(iii) for any legal expenses subsequently incurred
by such indemnified party in connection with the defense thereof other than
reasonable costs of investigation and of liaison with counsel so selected,
provided, however, that, if the defendants in any such action include both the
indemnified party and the indemnifying party and the indemnifying party shall
have reasonably concluded that there may be reasonable defenses available to
indemnified party which are different from or additional to those available to
the indemnifying party or if the interests of the indemnified party reasonably
may be deemed to conflict with the interests of the indemnifying party, the
indemnified parties, as a group, shall have the right to select one separate
counsel, reasonably satisfactory to the indemnified and indemnifying party, and
to assume such legal defenses and otherwise to participate in the defense of
such action, with the reasonable expenses and fees of such separate counsel and
other expenses related to such participation to be reimbursed by the
indemnifying party as incurred.

     

    (iv)        In
order to provide for just and equitable contribution in the event of joint
liability under the 1933 Act in any case in which either (i) a Subscriber, or
any controlling person of a Subscriber, makes a claim for indemnification
pursuant to this Section 9(f) but it is judicially determined (by the entry of a
final judgment or decree by a court of competent jurisdiction and the expiration
of time to appeal or the denial of the last right of appeal) that such
indemnification may not be enforced in such case notwithstanding the fact that
this Section 9(f) provides for indemnification in such case, or (ii)
contribution under the 1933 Act may be required on the part of the Subscriber or
controlling person of the Subscriber in circumstances for which indemnification
is not provided under this Section 9(f); then, and in each such case, the
Company and the Subscriber will contribute to the aggregate losses, claims,
damages or liabilities to which they may be subject (after contribution from
others) in such proportion so that the Subscriber is responsible only for the
portion represented by the percentage that the public offering price of its
securities offered by the registration statement bears to the public offering
price of all securities offered by such registration statement, provided,
however, that, in any such case, (y) the Subscriber will not be required to
contribute any amount in excess of the public offering price of all such
securities sold by it pursuant to such registration statement; and (z) no person
or entity guilty of fraudulent misrepresentation (within the meaning of Section
10(f) of the 1933 Act) will be entitled to contribution from any person or
entity who was not guilty of such fraudulent misrepresentation and provided,
further, however, that the liability of the Subscriber hereunder shall be
limited to the net proceeds actually received by the Subscriber from the sale of
Registrable Shares pursuant to such registration statement.

     

    
      
         

      

      
        28

        
          

        

      

      
         

      

    

     

    10. 
        Anti-dilution and Purchase
Rights.

    (a)           Right of Participation.   During
the period from the Final Closing Date through and including the first
anniversary of the Final Closing Date, the Subscribers shall be given not less
than ten business days prior written notice (the “Notice of Sale”) of any
proposed sale by the Company of its common stock or other securities or equity
linked debt obligations, except in connection with (i) full or partial
consideration in connection with a strategic merger, acquisition, consolidation
or purchase of substantially all of the securities or assets of corporation or
other entity which holders of such securities or debt are not at any time
granted registration rights, (ii) the Company’s issuance of securities in
connection with strategic license agreements and other partnering arrangements
so long as such issuances are not for the purpose of raising capital and which
holders of such securities or debt are not at any time granted registration
rights, (iii) the Company’s issuance of common stock or the issuances or grants
of options to purchase common stock to employees, directors, and consultants,
including the issuance of an undetermined amount of shares of common stock to
certain shareholders of the Company pursuant to that certain recapitalization of
the Company and the issuance of securities in connection with investor relations
services, and (iv) securities upon the exercise or exchange of or conversion of
any securities exercisable or exchangeable for or convertible into shares of
common stock issued and outstanding on the date of this Agreement and described
on Schedule 4(d)
(collectively the foregoing are “Excepted
Issuances”).  The Subscribers shall have the right during the
ten business days following receipt of the Notice of Sale (the “Notice Period”) to purchase in
the aggregate such offered common stock, debt or other securities in accordance
with the terms and conditions set forth in the Notice of Sale.  In the
event such terms and conditions are modified during the Notice Period, the
Subscribers shall be given prompt notice (the “Notice of Modification”) of
such modification and shall have the right during the ten business days
following the Notice of Modification to exercise such purchase
right.

     

    (b)           Most Favored Nations
Provision.   Other than in connection with Excepted
Issuances, if at any time within twenty four (24) months following the Closing,
the Company shall issue any common stock or securities convertible into or
exercisable for shares of common stock (or modify the conversion or exercise
price of any of the foregoing which may be outstanding) to any person or entity
at a price per share which shall be less than $2.21 per share, subject to
adjustment for stock dividends, subdivisions and combinations (the “Lower Price Issuance”),
without the consent of the Subscriber, then the Company shall issue, for each
such occasion, additional shares of common stock to the Subscriber respecting
those Purchased Shares that are then still owned by the Subscriber at the time
of the Lower Price Issuance so that the average per share purchase price of the
Purchased Shares owned by the Subscriber on the date of the Lower Price Issuance
plus such additional shares issued to Subscriber pursuant to this Section 10(b)
is equal to such other lower price per share.  The delivery to
Subscriber of the additional shares of common stock shall be not later than the
closing date of the transaction giving rise to the requirement to issue
additional shares of common stock.  Subscriber is granted piggyback
registration rights in connection with such additional shares of common
stock.  For purposes of the issuance and adjustment described in this
paragraph, the issuance of any security of the Company carrying the right to
convert such security into shares of common stock or of any warrant, right or
option to purchase common stock shall result in the issuance of the additional
shares of common stock upon the sooner of the agreement to or actual issuance of
such convertible security, warrant, right or option and again at any time upon
any subsequent issuances of shares of common stock upon exercise of such
conversion or purchase rights if such issuance is at a price lower than $2.21
per share, subject to adjustment for stock dividends, subdivisions and
combinations.  Common stock issued or issuable by the Company for no
consideration or for consideration that cannot be determined at the time of
issue will be deemed issuable or to have been issued for $0.00001 per share of
common stock.  The rights of Subscriber set forth in this Section 10
are in addition to any other rights the Subscriber has pursuant to this
Agreement, any Transaction Documents, and any other agreement referred to or
entered into in connection herewith or to which Subscriber and Company are
parties.

    
      
         

      

      
        29

        
          

        

      

      
         

      

    

     

    (c)          Other
Adjustments.

     

    (i)           Other
than in connection with Excepted Issuances, (x) if the Company’s actual after
tax net income under U.S. GAAP for the fiscal year ending December 31, 2009
(“Actual 2009 Net
Income”) is less than $13,000,000 (“2009 Targeted Net Income”), or
(y) if the Company’s actual after tax net income under U.S. GAAP for the fiscal
year ending December 31, 2010 (“Actual 2010 Net Income”) is
less than $17,000,000 (“2010
Targeted Net Income”, together with the 2009 Targeted Net Income, the
“Targeted Net Income”),
then the Company shall issue, for each such occasion, to each Subscriber on a
pro-rata basis (determined by dividing each Subscriber’s Purchase Price by the
aggregate Purchase Price delivered to the Company by the Subscribers hereunder),
additional amount of shares of Common Stock (the “Adjustment Shares”) equal to,
as applicable, (a)  the percentage of variation of the Actual 2009 Net
Income from the 2009 Targeted Net Income times the number of Purchased Shares
acquired by such Subscriber pursuant to this Agreement or (b) the percentage of
variation of the Actual 2010 Net Income from the 2010 Targeted Net Income times
the number of Purchased Shares acquired by such Subscriber pursuant to this
Agreement. For example, if the Actual 2009 Net Income is $11,700,000, which is a
variation of 10% of the 2009 Targeted Net Income, then the Company shall issue
to each Subscriber, shares of the Company’s Common Stock, equal to a total of
10% of the Purchased Shares acquired by such Subscriber hereunder.

     

    (ii)          The
delivery to Subscriber of the Adjustment Shares shall be not later than the
third business day after the filing of a Form 10-K with the Commission declaring
the annual audited results.

     

    (iii)          Notwithstanding
anything to the contrary contained herein, in determining whether the Company
has achieved either the 2009 Targeted Net Income or 2010 Targeted Net Income,
the Company may disregard any non-cash charge or expense required to be
recognized by the Company under the United States generally accepted accounting
principles (the “GAAP”),
including but not limited to the non-cash charges listed below. In addition, in
determining whether the Company has achieved either the 2009 Targeted Net Income
or the 2010 Targeted Net Income (as the case may be), (1) any liquidated damages
payable pursuant to the Transaction Documents and (2) any non-cash charges
expensed by the Company related to any Warrants or common stock issued pursuant
to this Transaction, in each case, shall not be included as expenses of the
Company in determining the Actual 2009 and 2010 Net Income. “Net Income” shall mean the
Company’s income after taxes for the fiscal year ending December 31, 2009 or
December 31, 2010 (as the case may be) in each case determined in accordance
with GAAP as reported in the 2009 Annual Report or 2010 Annual Report (as the
case may be) less the allowable exclusions listed above.

    
      
         

      

      
        30

        
          

        

      

      
         

      

    

     

    11.          Closing
Conditions.

     

    (a)          The
obligation hereunder of the Subscriber to acquire and pay for the Purchased
Securities is subject to the satisfaction or waiver, at or before the Closing,
of each of the conditions set forth below. These conditions are for the
Subscriber’s sole benefit and may be waived by the Subscriber at any time in its
sole discretion.

     

    (i)           The
representations and warranties of the Company contained in this Agreement shall
have been true and correct on the date of this Agreement and shall be true and
correct on the Closing Date as if given on and as of the Closing Date (except
for representations given as of a specific date, which representations shall be
true and correct as of such date), and on or before the Closing Date the Company
shall have performed all covenants and agreements of the Company contained
herein or in any of the other Transaction Documents required to be performed by
the Company on or before the Closing Date;

    

    (ii)          The
Company shall have delivered to the Escrow Agent a certificate, dated the
Closing Date, duly executed by its Chief Executive Officer, to the effect set
forth in subparagraph (i) of this Section 11(a);

    

    (iii)         The
Transaction Documents have been duly executed and delivered by the Company to
the Escrow Agent; and

    

    (iv)         On
the Closing Date, the Subscriber shall have received an opinion of the Crone Law
Group, counsel for the Company, dated the Closing Date, addressed to the
Subscribers, in the form attached as Exhibit D.

    

    (v)          On
or prior to the Closing Date, the Subscriber shall have received evidence of the
extension of the maturity date of the Related Party Debt executed by the debt
holder.

    

    (b)          The
obligation hereunder of the Company to issue and sell the Purchased Securities
to the Purchaser is subject to the satisfaction or waiver, at or before the
Closing, of each of the conditions set forth below. These conditions are for the
Company’s sole benefit and may be waived by the Company at any time in its sole
discretion.

    

    (i)           The
representations and warranties of the Subscriber in this Agreement and each of
the other Transaction Documents to which the Subscriber is a party shall be true
and correct in all material respects as of the date when made and as of the
Closing Date as though made at that time, except for representations and
warranties that are expressly made as of a particular date, which shall be true
and correct in all material respects as of such date;

    

    (ii)          The
Purchase Price for the Purchased Shares has been delivered to the escrow account
maintained by Anslow & Jaclin, LLP (the “Escrow
Agent”);

    
      
         

      

      
        31

        
          

        

      

      
         

      

    

     

    (iii)      
  The initial Closing Date shall have occurred on or before January
20, 2010 and shall have transmitted to the Company gross proceeds of at least
$2,500,000; and

    

    (iv)         The
Transaction Documents to which the Subscriber is a party have been duly executed
and delivered by the Subscriber to the Escrow Agent.

    

    12.         Appointment of Subscriber
Representative.

    

    (a)           Any
additional subscribers in Subsequent Closings hereby appoint Opus Holdings as
such subscriber’s representative (the “Subscriber Representative”) to
act on their collective behalf with respect to the Transaction Documents and all
amendments thereto, and the Subscriber Representative hereby accepts such
appointment.

    

    (b)           Such
subscribers hereby authorize the Subscriber Representative to negotiate and
accept on the subscriber’s behalf such additional terms of the Offering as the
Subscriber Representative shall deem at its sole discretion to be in the best
interest of such subscriber. All decisions of the Subscriber Representative with
respect to the foregoing shall be binding on such subscriber absent fraud or
willful misconduct.

    

    (c)           The
Company hereby agrees to expand to each additional subscriber the benefit of the
additional terms of the Offering accepted by the Subscriber Representative
pursuant to Section 12(b).

    

    13.          Miscellaneous.

     

    (a)           Notices.  All
notices, demands, requests, consents, approvals, and other communications
required or permitted hereunder shall be in writing and, unless otherwise
specified herein, shall be (i) personally served, (ii) deposited in the mail,
registered or certified, return receipt requested, postage prepaid, (iii)
delivered by reputable air courier service with charges prepaid, or (iv)
transmitted by hand delivery, telegram, or facsimile, addressed as set forth
below or to such other address as such party shall have specified most recently
by written notice.  Any notice or other communication required or
permitted to be given hereunder shall be deemed effective (a) upon hand delivery
or delivery by facsimile, with accurate confirmation generated by the
transmitting facsimile machine, at the address or number designated below
(if delivered on a business day during normal business hours where such notice
is to be received), or the first business day following such delivery (if
delivered other than on a business day during normal business hours where such
notice is to be received) or (b) on the second business day following the date
of mailing by express courier service, fully prepaid, addressed to such address,
or upon actual receipt of such mailing, whichever shall first occur. The
addresses for such communications shall be:

    
      
         

      

      
        32

        
          

        

      

      
         

      

    

    If to the
Company, to:

    

    Weikang
Bio-Technology Group Company, Inc.

    Attn: Mr.
Yin Wang, Chairman

    No. 365
Chengde Street, Daowai District, Harbin

    Heilongjiang
Province, PRC 150020

    facsimile:
+ 011 86-451-8835
5530

    

    With a
copy by fax only to (which copy shall not constitute notice):

    

    If to the
Subscribers:

    To each
of the addresses and facsimile numbers listed on the signature pages of this
Agreement

    

    With a
copy by fax only to (which copy shall not constitute notice):

    Anslow
& Jaclin LLP

    Attn:
Kristina L. Trauger, Esq.

    195 Route
9 South, 2nd
Floor

    Manalapan,
NJ 07726

    facsimile:
(732) 577-1188

     

     (b)          Entire Agreement;
Amendment. This Agreement and the other Transaction Documents contain the
entire understanding and agreement of the parties with respect to the matters
covered hereby and, except as specifically set forth herein or in the
Transaction Documents, neither the Company nor any of the Subscribers makes any
representations, warranty, covenant or undertaking with respect to such matters
and they supersede all prior understandings and agreements with respect to said
subject matter, all of which are merged herein. No provision of this Agreement
nor any of the Transaction Documents may be waived or amended other than by a
written instrument signed by the Company and the holders of at least fifty
percent (50%) of the total shares of common stock purchased in the Offering and
then outstanding (the “Majority
Holders”), and no provision hereof may be waived other than by a written
instrument signed by the party against whom enforcement of any such waiver is
sought. No such amendment shall be effective to the extent that it applies to
less than all of the holders of the Purchased Shares then outstanding. No
consideration shall be offered or paid to any person to amend or consent to a
waiver or modification of any provision of any of the Transaction Documents
unless the same consideration is also offered to all of the parties to the
Transaction Documents or holders of Purchased Shares, as the case may
be.

     

     (c)           Counterparts/Execution.  This
Agreement may be executed in any number of counterparts and by the different
signatories hereto on separate counterparts, each of which, when so executed,
shall be deemed an original, but all such counterparts shall constitute but one
and the same instrument.  This Agreement may be executed by facsimile
transmission, PDF, electronic signature or other similar electronic means with
the same force and effect as if such signature page were an original
thereof.

    
      
         

      

      
        33

        
          

        

      

      
         

      

    

     

    (d)           Law Governing this
Agreement.  This Agreement shall be governed by and construed
in accordance with the laws of the State of New York without regard to
principles of conflicts of laws. Any action brought by either party against the
other concerning the transactions contemplated by this Agreement shall be
brought only in the state courts of New York or in the federal courts located in
the state and county of New York.  The parties to this Agreement
hereby irrevocably waive any objection to jurisdiction and venue of any action
instituted hereunder and shall not assert any defense based on lack of
jurisdiction or venue or based upon forum non
conveniens.  The parties executing this Agreement
and other agreements referred to herein or delivered in connection herewith on
behalf of the Company agree to submit to the in personam jurisdiction of such
courts and hereby irrevocably waive trial by jury.  The
prevailing party shall be entitled to recover from the other party its
reasonable attorney’s fees and costs.  In the event that any provision
of this Agreement or any other agreement delivered in connection herewith is
invalid or unenforceable under any applicable statute or rule of law, then such
provision shall be deemed inoperative to the extent that it may conflict
therewith and shall be deemed modified to conform with such statute or rule of
law.  Any such provision which may prove invalid or unenforceable
under any law shall not affect the validity or enforceability of any other
provision of any agreement.  Each party hereby irrevocably waives
personal service of process and consents to process being served in any suit,
action or proceeding in connection with this Agreement or any other Transaction
Documents by mailing a copy thereof via registered or certified mail or
overnight delivery (with evidence of delivery) to such party at the address in
effect for notices to it under this Agreement and agrees that such service shall
constitute good and sufficient service of process and notice
thereof.  Nothing contained herein shall be deemed to limit in any way
any right to serve process in any other manner permitted by law.

     

    (e)           Specific Enforcement,
Consent to Jurisdiction.  The Company and Subscribers
acknowledge and agree that irreparable damage would occur in the event that any
of the provisions of this Agreement were not performed in accordance with their
specific terms or were otherwise breached.  It is accordingly agreed
that the parties shall be entitled to seek an injunction or injunctions to
prevent or cure breaches of the provisions of this Agreement and to enforce
specifically the terms and provisions hereof, this being in addition to any
other remedy to which any of them may be entitled by law or
equity.  Subject to Section 13(d) hereof, the Company and the
Subscribers hereby irrevocably waive, and agree not to assert in any such suit,
action or proceeding, any claim that it is not personally subject to the
jurisdiction in New York of such court, that the suit, action or proceeding is
brought in an inconvenient forum or that the venue of the suit, action or
proceeding is improper.  Nothing in this Section shall affect or limit
any right to serve process in any other manner permitted by law.

     

    (f)       
    Damages.   In
the event the Subscriber is entitled to receive any liquidated damages pursuant
to the Transactions Documents, the Subscriber may elect to receive the greater
of actual damages or such liquidated damages.

     

    (g)           Maximum
Payments.   Nothing contained herein or in any document
referred to herein or delivered in connection herewith shall be deemed to
establish or require the payment of a rate of interest or other charges in
excess of the maximum permitted by applicable law.  In the event that
the rate of interest or dividends required to be paid or other charges
hereunder exceed the maximum permitted by such law, any payments in excess of
such maximum shall be credited against amounts owed by the Company to the
Subscriber and thus refunded to the Company.

    
      
         

      

      
        34

        
          

        

      

      
         

      

    

     

    (h)           Calendar
Days.   All references to “days” in the Transaction
Documents shall mean calendar days unless otherwise stated.  The terms
“business days” and “trading days” shall mean days that the New York Stock
Exchange is open for trading for three or more hours.  Time periods
shall be determined as if the relevant action, calculation or time period were
occurring in New York City.  Any deadline that falls on a non-business
day in any of the Transaction Documents shall be automatically extended to the
next business day and interest, if any, shall be calculated and payable through
such extended period.

     

    (i)       
    Captions: Certain
Definitions.  The captions of the various sections and
paragraphs of this Agreement have been inserted only for the purposes of
convenience; such captions are not a part of this Agreement and shall not be
deemed in any manner to modify, explain, enlarge or restrict any of the
provisions of this Agreement.  As used in this Agreement the term
“person” shall mean and
include an individual, a partnership, a joint venture, a corporation, a limited
liability company, a trust, an unincorporated organization and a government or
any department or agency thereof.

     

    (j)         
  Severability.  In
the event that any term or provision of this Agreement shall be finally
determined to be superseded, invalid, illegal or otherwise unenforceable
pursuant to applicable law by an authority having jurisdiction and venue, that
determination shall not impair or otherwise affect the validity, legality or
enforceability: (i) by or before that authority of the remaining terms and
provisions of this Agreement, which shall be enforced as if the unenforceable
term or provision were deleted, or (ii) by or before any other authority of any
of the terms and provisions of this Agreement.

     

    [Signature
Pages Follow]

     

    
      
         

      

      
        35

        
          

        

      

      
         

      

    

     

    SIGNATURE PAGE TO SUBSCRIPTION
AGREEMENT

    

    Please
acknowledge your acceptance of the foregoing Subscription Agreement with Weikang
Bio-Technology Group Co., Inc. by signing and returning a copy to the Company
whereupon it shall become a binding agreement.

    

    NUMBER
OF SHARES              
                     
x    
$1.70     =              
                     
(the “Purchase
Price”)

    

    
      
        
          
            
              
                
                  
                    
                      
                        
                          
                            
                              
                                	
                                            

                                      	 	
                                         

                                      
	
                                        Signature

                                      	 	
                                        Signature
      (if purchasing jointly)

                                      
	 
      	 	 
      
	
                                            

                                      	  	
                                         

                                      
	
                                        Name
      Typed or Printed

                                      	 	
                                        Name
      Typed or Printed

                                      
	 
      	 	 
      
	
                                            

                                      	 	
                                            

                                      
	
                                        Entity
      Name

                                      	 	
                                        Entity
      Name

                                      
	 
      	 	 
      
	
                                            

                                      	 	
                                            

                                      
	
                                        Address

                                      	 	
                                        Address

                                      
	 
      	 	 
      
	
                                            

                                      	 	
                                            

                                      
	
                                        City,
      State and Zip Code

                                      	 	
                                        City,
      State and Zip Code

                                      
	 
      	 	 
      
	
                                            

                                      	 	
                                            

                                      
	
                                        Telephone
      - Business

                                      	 	
                                        Telephone
      - Business

                                      
	 
      	 	 
      
	
                                            

                                      	 	
                                            

                                      
	
                                        Telephone
      – Residence

                                      	 	
                                        Telephone
      – Residence

                                      
	 
      	 	 
      
	
                                            

                                      	 	
                                            

                                      
	
                                        Facsimile
      – Business

                                      	 	
                                        Facsimile
      - Business

                                      
	 
      	 	 
      
	
                                            

                                      	 	
                                            

                                      
	
                                        Facsimile
      – Residence

                                      	 	
                                        Facsimile
      – Residence

                                      
	 
      	 	 
      
	
                                            

                                      	 	
                                            

                                      
	
                                        Tax
      ID # or Social Security #

                                      	 	
                                        Tax
      ID # or Social Security
#

                                      

                              

                            

                          

                        

                      

                    

                  

                

              

            

          

        

      

    

    

    Name in
which securities should be issued:                                                                                               

     

    Dated: January
20, 2010

     

    
      
         

      

      
        36

        
          

        

      

      
         

      

    

    This
Subscription Agreement is agreed to and accepted as of January 20,
2010.

     

    
      
        
          	
                  WEIKANG
      BIO-TECHNOLOGY

                  GROUP
      COMPANY, INC.

                
	 
      	 
      
	
                  By: 

                	
                      

                
	 
      	
                  Name:

                
	 
      	
                  Title:

                

        

      

    

    
      
         

      

      
        37

        
          

        

      

      
         

      

    

    LIST OF EXHIBITS AND
SCHEDULES

     

    
      	
              Exhibit
      A

            	
              Escrow
      Agreement

            

    

     

    
      	
              Exhibit
      B

            	
              Investor
      Relations Escrow Agreement

            

    

     

    
      	
              Exhibit
      C

            	
              Form
      of Lockup Agreement

            

    

     

    
      	
              Exhibit
      D

            	
              Form
      of Legal Opinion

            

    

     

    
      	
              Exhibit
      E

            	
              Selling
      Securityholder Questionnaire

            

    

     

    
      	
              Exhibit
      F

            	
              Series
      A Warrant

            

    

     

    
      	
              Exhibit
      G

            	
              Series
      B Warrant

            

    

    
      
         

      

      
        38THIS
WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE HEREOF HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”) OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE
DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE
STATE SECURITIES LAWS OR THE ISSUER SHALL HAVE RECEIVED AN OPINION OF COUNSEL
REASONABLY SATISFACTORY TO THE ISSUER THAT REGISTRATION OF SUCH SECURITIES UNDER
THE SECURITIES ACT AND UNDER THE PROVISIONS OF APPLICABLE STATE SECURITIES LAWS
IS NOT REQUIRED.

     

    SERIES A
WARRANT TO PURCHASE

     

    SHARES OF
COMMON STOCK

     

    OF

     

    WEIKANG
BIO-TECHNOLOGY GROUP COMPANY, INC.

     

    Expires
January 20, 2013

    

    
      
        	
                No.: ______

              	
                Number of Shares: [_____]            

              
	
                Date
      of Issuance: January 20, 2010

              	 
      

      

    

     

    FOR VALUE
RECEIVED, the undersigned, Weikang Bio-Technology Group Company, Inc., a Nevada
corporation (together with its successors and assigns, the “Issuer”), hereby
certifies that ____________________________________ (the “Holder”) or its
registered assigns is entitled to subscribe for and purchase, during the Term
(as hereinafter defined), ______ (____) shares (subject to adjustment as
hereinafter provided) of the duly authorized, validly issued, fully paid and
non-assessable Common Stock of the Issuer, at an exercise price per share equal
to the Warrant Price then in effect, subject, however, to the provisions and
upon the terms and conditions hereinafter set forth. Capitalized terms used in
this Warrant and not otherwise defined herein shall have the respective meanings
specified in Section 9 hereof.

     

    1.  
Term. The term
of this Warrant shall commence on January 20, 2010 and shall expire at 6:00
p.m., Eastern Time, on January 20, 2013 (such period being the “Term” and such date,
the “Termination
Date”).

     

    2.  
Method of Exercise;
Payment; Issuance of New Warrant; Transfer and Exchange.

     

    (a)
  Time of
Exercise. The purchase rights represented by this Warrant may be
exercised in whole or in part during the Term for such number of shares of
Common Stock set forth above.

     

    (b)
  Method of
Exercise. The Holder hereof may exercise this Warrant, in whole or in
part, by the surrender of this Warrant (with the exercise form attached hereto
duly executed (“Notice
of Exercise”)) at the principal office of the Issuer, and by the payment
to the Issuer of an amount of consideration therefor equal to the Warrant Price
in effect on the date of such exercise multiplied by the number of shares of
Warrant Stock with respect to which this Warrant is then being exercised,
payable at such Holder’s election (i) by certified or official bank check or by
wire transfer to an account designated by the Issuer, (ii) by “cashless
exercise” in accordance with the provisions of subsection (c) of this Section 2,
or (iii) by a combination of the foregoing methods of payment selected by the
Holder of this Warrant.

     

    (c)
  Cashless
Exercise. Notwithstanding any provision herein to the contrary and
commencing six (6) months following the Original Issue Date, if (i) the Per
Share Market Value of one share of Common Stock is greater than the Warrant
Price (at the date of calculation as set forth below) and (ii) a registration
statement under the Securities Act providing for the resale of the Warrant Stock
is not then in effect by the date such registration statement is required to be
effective pursuant to the Subscription Agreement (as defined in Section 8
hereof) or not effective at any time during the Effectiveness Period (as defined
in the Subscription Agreement) in accordance with the terms of the Subscription
Agreement, in lieu of exercising this Warrant by payment of cash, the Holder may
elect to exercise this Warrant by a cashless exercise and shall receive the
number of shares of Common Stock equal to an amount (as determined below) by
surrender of this Warrant at the principal office of the Issuer together with
the properly endorsed Notice of Exercise in which event the Issuer shall issue
to the Holder a number of shares of Common Stock computed using the following
formula:

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

    

    
      
        
          
            	 
      	
                    X =
      Y - (A)(Y)

                  
	
                      

                  	
                                      B

                  
	 
      	 
      	 
      
	
                      Where

                  	
                    X
      =

                  	
                    the
      number of shares of Common Stock to be issued to the
    Holder.

                  
	 
      	 
      	 
      
	 
      	
                    Y
      =

                  	
                    the
      number of shares of Warrant Stock issuable upon exercise of this Warrant
      in accordance with the terms of this Warrant by means of a cash exercise
      rather than a cashless exercise.

                  
	 
      	 
      	 
      
	 
      	
                    A
      =

                  	
                    the
      Warrant Price.

                  
	 
      	 
      	 
      
	 
      	
                    B
      =

                  	
                    the
      Per Share Market Value of one share of Common Stock on the Trading Day
      immediately preceding the date of such
election.

                  

          

        

      

    

     

    (d)
  Issuance of
Stock Certificates. In the event of any exercise of this Warrant in
accordance with and subject to the terms and conditions hereof, certificates for
the shares of Warrant Stock so purchased shall be dated the date of such
exercise and delivered to the Holder hereof within a reasonable time, not
exceeding five (5) Trading Days after such exercise (the “Delivery Date”) or,
at the request of the Holder (provided that a registration statement under the
Securities Act providing for the resale of the Warrant Stock is then in effect
or that the shares of Warrant Stock are otherwise exempt from registration),
issued and delivered to the Depository Trust Company (“DTC”) account on the
Holder’s behalf via the Deposit Withdrawal Agent Commission System (“DWAC”) within a
reasonable time, not exceeding five (5) Trading Days after such exercise, and
the Holder hereof shall be deemed for all purposes to be the holder of the
shares of Warrant Stock so purchased as of the date of such exercise.
Notwithstanding the foregoing to the contrary, the Issuer or its transfer agent
shall only be obligated to issue and deliver the shares to the DTC on a holder’s
behalf via DWAC if such exercise is in connection with a sale or other exemption
from registration by which the shares may be issued without a restrictive
legend. The Holder shall deliver this original Warrant, or an indemnification
undertaking with respect to such Warrant in the case of its loss, theft or
destruction, at such time that this Warrant is fully exercised. With respect to
partial exercises of this Warrant, the Issuer shall keep written records for the
Holder of the number of shares of Warrant Stock exercised as of each date of
exercise.

     

    (e)
  Compensation
for Buy-In on Failure to Timely Deliver Certificates Upon Exercise. In
addition to any other rights available to the Holder, if the Issuer fails to
cause its transfer agent to transmit to the Holder a certificate or certificates
representing the Warrant Stock pursuant to an exercise on or before the Delivery
Date, and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) shares of Common Stock to deliver
in satisfaction of a sale by the Holder of the Warrant Stock which the Holder
anticipated receiving upon such exercise (a “Buy-In”), then the
Issuer shall: (1) pay in cash to the Holder the amount by which (x) the Holder’s
total purchase price (including brokerage commissions, if any) for the shares of
Common Stock so purchased exceeds (y) the amount obtained by multiplying (A) the
number of shares of Warrant Stock that the Issuer was required to deliver to the
Holder in connection with the exercise at issue times (B) the price at which the
sell order giving rise to such purchase obligation was executed, and (2) at the
option of the holder, either reinstate the portion of the Warrant and equivalent
number of shares of Warrant Stock for which such exercise was not honored or
deliver to the Holder the number of shares of Common Stock that would have been
issued had the Issuer timely complied with its exercise and delivery obligations
hereunder. For example, if the Holder purchases Common Stock having a total
purchase price of $11,000 to cover a Buy-In with respect to an attempted
exercise of shares of Common Stock with an aggregate sale price giving rise to
such purchase obligation of $10,000, under clause (1) of the immediately
preceding sentence the Issuer shall be required to pay the Holder $1,000. The
Holder shall provide the Issuer written notice indicating the amounts payable to
the Holder in respect of the Buy-In, together with applicable confirmations and
other evidence reasonably requested by the Issuer. Nothing herein shall limit a
Holder’s right to pursue any other remedies available to it hereunder, at law or
in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Issuer’s failure to timely deliver
certificates representing shares of Common Stock upon exercise of this Warrant
as required pursuant to the terms hereof.

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    (f)
  Transferability
of Warrant. Subject to Section 2(h) hereof, this Warrant may be
transferred by a Holder, in whole or in part, to an “accredited investor” as
defined in Regulation D under the Securities Act without the consent of the
Issuer. If transferred pursuant to this paragraph, this Warrant may be
transferred on the books of the Issuer by the Holder hereof in person or by duly
authorized attorney, upon surrender of this Warrant at the principal office of
the Issuer, properly endorsed (by the Holder executing an assignment in the form
attached hereto) and upon payment of any necessary transfer tax or other
governmental charge imposed upon such transfer. This Warrant is exchangeable at
the principal office of the Issuer for Warrants to purchase the same aggregate
number of shares of Warrant Stock, each new Warrant to represent the right to
purchase such number of shares of Warrant Stock as the Holder hereof shall
designate at the time of such exchange. All Warrants issued on transfers or
exchanges shall be dated the Original Issue Date and shall be identical with
this Warrant except as to the number of shares of Warrant Stock issuable
pursuant thereto.

     

    (g)
  Continuing
Rights of Holder. The Issuer will, at the time of or at any time after
each exercise of this Warrant, upon the request of the Holder hereof,
acknowledge in writing the extent, if any, of its continuing obligation to
afford to such Holder all rights to which such Holder shall continue to be
entitled after such exercise in accordance with the terms of this Warrant, provided that if any
such Holder shall fail to make any such request, the failure shall not affect
the continuing obligation of the Issuer to afford such rights to such
Holder.

    

    (h)
  Compliance with
Securities Laws.

     

    (i)
  The Holder of this Warrant, by acceptance hereof, acknowledges that this
Warrant and the shares of Warrant Stock to be issued upon exercise hereof are
being acquired solely for the Holder’s own account and not as a nominee for any
other party, and for investment, and that the Holder will not offer, sell or
otherwise dispose of this Warrant or any shares of Warrant Stock to be issued
upon exercise hereof except pursuant to an effective registration statement, or
an exemption from registration, under the Securities Act and any applicable
state securities laws.

     

    (ii)
  Except as provided in paragraph (iii) below, this Warrant and all
certificates representing shares of Warrant Stock issued upon exercise hereof
shall be stamped or imprinted with a legend in substantially the following
form:

     

    THIS
WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE HEREOF HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”) OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE
DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE
STATE SECURITIES LAWS OR THE ISSUER SHALL HAVE RECEIVED AN OPINION OF COUNSEL
REASONABLY SATISFACTORY TO THE ISSUER THAT REGISTRATION OF SUCH SECURITIES UNDER
THE SECURITIES ACT AND UNDER THE PROVISIONS OF APPLICABLE STATE SECURITIES LAWS
IS NOT REQUIRED.

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    (iii)
  The Issuer agrees to reissue this Warrant or certificates representing
any of the Warrant Stock, without the legend set forth above if at such time,
prior to making any transfer of any such securities, the Holder shall give
written notice to the Issuer describing the manner and terms of such transfer.
Such proposed transfer will not be effected until: (a) either (i) the Issuer has
received an opinion of counsel reasonably satisfactory to the Issuer, to the
effect that the registration of such securities under the Securities Act is not
required in connection with such proposed transfer, (ii) a registration
statement under the Securities Act covering such proposed disposition has been
filed by the Issuer with the United States Securities and Exchange Commission
and has become effective under the Securities Act, or (iii) the Issuer has
received other evidence reasonably satisfactory to the Issuer that such
registration and qualification under the Securities Act and state securities
laws are not required; and (b) either (i) the Issuer has received an opinion of
counsel reasonably satisfactory to the Issuer, to the effect that registration
or qualification under the securities or “blue sky” laws of any state is not
required in connection with such proposed disposition, or (ii) compliance with
applicable state securities or “blue sky” laws has been effected or a valid
exemption exists with respect thereto. The Issuer will respond to any such
notice from a holder within five (5) Trading Days. In the case of any proposed
transfer under this Section 2(h), the Issuer will use reasonable efforts to
comply with any such applicable state securities or “blue sky” laws, but shall
in no event be required, (x) to qualify to do business in any state where it is
not then qualified, (y) to take any action that would subject it to tax or to
the general service of process in any state where it is not then subject, or (z)
to comply with state securities or “blue sky” laws of any state for which
registration by coordination is unavailable to the Issuer. The restrictions on
transfer contained in this Section 2(h) shall be in addition to, and not by way
of limitation of, any other restrictions on transfer contained in any other
section of this Warrant. Whenever a certificate representing the Warrant Stock
is required to be issued to the Holder without a legend, in lieu of delivering
physical certificates representing the Warrant Stock, the Issuer shall cause its
transfer agent to electronically transmit the Warrant Stock to the Holder by
crediting the account of the Holder or Holder’s Prime Broker with DTC through
its DWAC system (to the extent not inconsistent with any provisions of this
Warrant or the Subscription Agreement).

     

    (i)
  Accredited
Investor Status. In no event may the Holder exercise this Warrant in
whole or in part unless the Holder is an “accredited investor” as defined in
Regulation D under the Securities Act.

     

    3.  
Stock Fully Paid;
Reservation and Listing of Shares; Covenants.

     

    (a)
  Stock Fully
Paid. The Issuer represents, warrants, covenants and agrees that all
shares of Warrant Stock which may be issued upon the exercise of this Warrant or
otherwise hereunder will, when issued in accordance with the terms of this
Warrant, be duly authorized, validly issued, fully paid and non-assessable and
free from all taxes, liens and charges created by or through the Issuer. The
Issuer further covenants and agrees that during the period within which this
Warrant may be exercised, the Issuer will at all times have authorized and
reserved for the purpose of the issuance upon exercise of this Warrant a number
of authorized but unissued shares of Common Stock equal to at least the number
of shares of Common Stock issuable upon exercise of this Warrant without regard
to any limitations on exercise.

     

    (b)
  Reservation. If any
shares of Common Stock required to be reserved for issuance upon exercise of
this Warrant or as otherwise provided hereunder require registration or
qualification with any Governmental Authority under any federal or state law
before such shares may be so issued, the Issuer will in good faith use its best
efforts as expeditiously as possible at its expense to cause such shares to be
duly registered or qualified, in accordance with the terms and provisions of the
Subscription Agreement. If the Issuer shall list any shares of Common Stock on
any securities exchange or market it will, at its expense, list thereon, and
maintain and increase when necessary such listing, of, all shares of Warrant
Stock from time to time issued upon exercise of this Warrant or as otherwise
provided hereunder (provided that such
Warrant Stock has been registered pursuant to a registration statement under the
Securities Act then in effect), and, to the extent permissible under the
applicable securities exchange rules, all unissued shares of Warrant Stock which
are at any time issuable hereunder, so long as any shares of Common Stock shall
be so listed. The Issuer will also so list on each securities exchange or
market, and will maintain such listing of, any other securities which the Holder
of this Warrant shall be entitled to receive upon the exercise of this Warrant
if at the time any securities of the same class shall be listed on such
securities exchange or market by the Issuer.

     

    (c)
  Covenants. The Issuer
shall not by any action including, without limitation, amending the Certificate
of Incorporation or the by-laws of the Issuer, or through any reorganization,
transfer of assets, consolidation, merger, dissolution, issue or sale of
securities or any other action, avoid or seek to avoid the observance or
performance of any of the terms of this Warrant, but will at all times in good
faith assist in the carrying out of all such terms and in the taking of all such
actions as may be necessary or appropriate to protect the rights of the Holder
hereof against dilution (to the extent specifically provided herein) or
impairment. Without limiting the generality of the foregoing, the Issuer will
(i) not permit the par value, if any, of its Common Stock to exceed the then
effective Warrant Price, (ii) not amend or modify any provision of the
Certificate of Incorporation or by-laws of the Issuer in any manner that would
adversely affect the rights of the Holders of the Warrants, (iii) take all such
action as may be reasonably necessary in order that the Issuer may validly and
legally issue fully paid and nonassessable shares of Common Stock, free and
clear of any liens, claims, encumbrances and restrictions (other than as
provided herein) upon the exercise of this Warrant, and (iv) use its best
efforts to obtain all such authorizations, exemptions or consents from any
public regulatory body having jurisdiction thereof as may be reasonably
necessary to enable the Issuer to perform its obligations under this
Warrant.

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

     

    (d)
  Loss, Theft,
Destruction of Warrants. Upon receipt of evidence satisfactory to the
Issuer of the ownership of and the loss, theft, destruction or mutilation of any
Warrant and, in the case of any such loss, theft or destruction, upon receipt of
indemnity or security satisfactory to the Issuer or, in the case of any such
mutilation, upon surrender and cancellation of such Warrant, the Issuer will
make and deliver, in lieu of such lost, stolen, destroyed or mutilated Warrant,
a new Warrant of like tenor and representing the right to purchase the same
number of shares of Common Stock.

     

    (e)
  Payment of
Taxes. The Issuer will pay any documentary stamp taxes attributable to
the initial issuance of the Warrant Stock issuable upon exercise of this
Warrant; provided, however, that the
Issuer shall not be required to pay any tax or taxes which may be payable in
respect of any transfer involved in the issuance or delivery of any certificates
representing Warrant Stock in a name other than that of the Holder in respect to
which such shares are issued.

     

    4.  
Adjustment of Warrant
Price. The price at which such shares of Warrant Stock may be purchased
upon exercise of this Warrant shall be subject to adjustment from time to time
as set forth in this Section 4. The Issuer shall give the Holder notice of any
event described below which requires an adjustment pursuant to this Section 4 in
accordance with the notice provisions set forth in Section 5.

     

    (a)
  Recapitalization,
Reorganization, Reclassification, Consolidation, Merger or
Sale.

     

    (i)
  In case the Issuer after the Original Issue Date shall do any of the
following (each, a “Triggering Event”):
(a) consolidate or merge with or into any other Person and the Issuer shall not
be the continuing or surviving corporation of such consolidation or merger, or
(b) permit any other Person to consolidate with or merge into the Issuer and the
Issuer shall be the continuing or surviving Person but, in connection with such
consolidation or merger, any Capital Stock of the Issuer shall be changed into
or exchanged for Securities of any other Person or cash or any other property,
or (c) transfer all or substantially all of its properties or assets to any
other Person, or (d) effect a capital reorganization or reclassification of its
Capital Stock, then, and in the case of each such Triggering Event, proper
provision shall be made to the Warrant Price and the number of shares of Warrant
Stock that may be purchased upon exercise of this Warrant so that, upon the
basis and the terms and in the manner provided in this Warrant, the Holder of
this Warrant shall be entitled upon the exercise hereof at any time after the
consummation of such Triggering Event, to the extent this Warrant is not
exercised prior to such Triggering Event, to receive at the Warrant Price in
effect at the time immediately prior to the consummation of such Triggering
Event, in lieu of the Common Stock issuable upon such exercise of this Warrant
prior to such Triggering Event, the Securities, cash and property to which such
Holder would have been entitled upon the consummation of such Triggering Event
if such Holder had exercised the rights represented by this Warrant immediately
prior thereto (including the right of a shareholder to elect the type of
consideration it will receive upon a Triggering Event), subject to adjustments
(subsequent to such corporate action) as nearly equivalent as possible to the
adjustments provided for elsewhere in this Section 4; provided , however , the Holder
at its option may elect to receive an amount in unregistered shares of the
common stock of the surviving entity equal to the value of this Warrant
calculated in accordance with the Black-Scholes formula. Immediately upon the
occurrence of a Triggering Event, the Issuer shall notify the Holder in writing
of such Triggering Event and provide the calculations in determining the number
of shares of Warrant Stock issuable upon exercise of the new warrant and the
adjusted Warrant Price. Upon the Holder’s request, the continuing or surviving
corporation as a result of such Triggering Event shall issue to the Holder a new
warrant of like tenor evidencing the right to purchase the adjusted number of
shares of Warrant Stock and the adjusted Warrant Price pursuant to the terms and
provisions of this Section 4(a)(i).  In the event that the surviving
entity pursuant to any such Triggering Event is not a public company that is
registered pursuant to the Exchange Act of 1934, as amended, or its common stock
is not listed or quoted on a national securities exchange, national automated
quotation system or the OTC Bulletin Board, then the Holder at its option may
elect to receive an amount in unregistered shares of the common stock of the
surviving entity equal to the value of this Warrant calculated in accordance
with the Black-Scholes formula.

     

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

    

    (ii)
  In the event that the Holder has elected not to exercise this Warrant
prior to the consummation of a Triggering Event and has also elected not to
receive an amount in unregistered shares equal to the value of this Warrant
calculated in accordance with the Black-Scholes formula pursuant to the
provisions of Section 4(a)(i) above, so long as the surviving entity pursuant to
any Triggering Event is a company that has a class of equity securities
registered pursuant to the Exchange Act and its common stock is listed or quoted
on a national securities exchange, national automated quotation system or the
OTC Bulletin Board, the surviving entity and/or each Person (other than the
Issuer) which may be required to deliver any Securities, cash or property upon
the exercise of this Warrant as provided herein shall assume, by written
instrument delivered to, and reasonably satisfactory to, the Holder of this
Warrant, (A) the obligations of the Issuer under this Warrant (and if the Issuer
shall survive the consummation of such Triggering Event, such assumption shall
be in addition to, and shall not release the Issuer from, any continuing
obligations of the Issuer under this Warrant) and (B) the obligation to deliver
to such Holder such Securities, cash or property as, in accordance with the
foregoing provisions of this subsection (a), such Holder shall be entitled to
receive, and the surviving entity and/or each such Person shall have similarly
delivered to such Holder an opinion of counsel for the surviving entity and/or
each such Person, which counsel shall be reasonably satisfactory to such Holder,
or in the alternative, a written acknowledgement executed by the President or
Chief Financial Officer of the Issuer, stating that this Warrant shall
thereafter continue in full force and effect and the terms hereof (including,
without limitation, all of the provisions of this subsection (a)) shall be
applicable to the Securities, cash or property which the surviving entity and/or
each such Person may be required to deliver upon any exercise of this Warrant or
the exercise of any rights pursuant hereto.

     

    (b)
  Stock
Dividends, Subdivisions and Combinations. If at any time the Issuer
shall:

     

    (i)
    make or issue or set a record date for the holders of the
Common Stock for the purpose of entitling them to receive a dividend payable in,
or other distribution of, shares of Common Stock,

     

    (ii)   
subdivide its outstanding shares of Common Stock into a larger number of shares
of Common Stock, or

     

    (iii)  
combine its outstanding shares of Common Stock into a smaller number of shares
of Common Stock,

     

    then (1)
the number of shares of Common Stock for which this Warrant is exercisable
immediately after the occurrence of any such event shall be adjusted to equal
the number of shares of Common Stock which a record holder of the same number of
shares of Common Stock for which this Warrant is exercisable immediately prior
to the occurrence of such event would own or be entitled to receive after the
happening of such event, and (2) the Warrant Price then in effect shall be
adjusted to equal (A) the Warrant Price then in effect multiplied by the number
of shares of Common Stock for which this Warrant is exercisable immediately
prior to the adjustment divided by (B) the number of shares of Common Stock for
which this Warrant is exercisable immediately after such
adjustment.

     

    (c)
  Certain Other
Distributions. If at any time the Issuer shall make or issue or set a
record date for the holders of the Common Stock for the purpose of entitling
them to receive any dividend or other distribution of:

     

    (i)
    cash,

     

    (ii)
  any evidences of its indebtedness, any shares of stock of any class or
any other securities or property of any nature whatsoever (other than cash,
Common Stock Equivalents or Additional Shares of Common Stock), or

     

    (iii)
  any warrants or other rights to subscribe for or purchase any evidences
of its indebtedness, any shares of stock of any class or any other securities or
property of any nature whatsoever (other than cash, Common Stock Equivalents or
Additional Shares of Common Stock),

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

    

    then (1)
the number of shares of Common Stock for which this Warrant is exercisable shall
be adjusted to equal the product of the number of shares of Common Stock for
which this Warrant is exercisable immediately prior to such adjustment
multiplied by a fraction (A) the numerator of which shall be the Per Share
Market Value of Common Stock at the date of taking such record and (B) the
denominator of which shall be such Per Share Market Value minus the amount
allocable to one share of Common Stock of any such cash so distributable and of
the fair value (as determined in good faith by the Board of Directors of the
Issuer and supported by an opinion from an investment banking firm mutually
agreed upon by the Issuer and the Holder) of any and all such evidences of
indebtedness, shares of stock, other securities or property or warrants or other
subscription or purchase rights so distributable, and (2) the Warrant Price then
in effect shall be adjusted to equal (A) the Warrant Price then in effect
multiplied by the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to the adjustment divided by (B) the number of
shares of Common Stock for which this Warrant is exercisable immediately after
such adjustment. A reclassification of the Common Stock (other than a change in
par value, or from par value to no par value or from no par value to par value)
into shares of Common Stock and shares of any other class of stock shall be
deemed a distribution by the Issuer to the holders of its Common Stock of such
shares of such other class of stock within the meaning of this Section 4(c) and,
if the outstanding shares of Common Stock shall be changed into a larger or
smaller number of shares of Common Stock as a part of such reclassification,
such change shall be deemed a subdivision or combination, as the case may be, of
the outstanding shares of Common Stock within the meaning of Section
4(b).

    

     (e)
  Issuance of
Common Stock Equivalents. In the event the Issuer shall take a record of
the holders of its Common Stock for the purpose of entitling them to receive a
distribution of, or shall in any manner (whether directly or by assumption in a
merger in which the Issuer is the surviving corporation) issue or sell, any
Common Stock Equivalents, whether or not the rights to exchange or convert
thereunder are immediately exercisable, and the price per share for which Common
Stock is issuable upon such conversion or exchange shall be less than the
Warrant Price in effect immediately prior to the time of such issue or sale, or
if, after any such issuance of Common Stock Equivalents, the price per share for
which Additional Shares of Common Stock may be issuable thereafter is amended or
adjusted, and such price as so amended shall be less than the Warrant Price in
effect at the time of such amendment or adjustment, then the Warrant Price then
in effect shall be adjusted as provided in Section 4(d). No further adjustments
of the number of shares of Common Stock for which this Warrant is exercisable
and the Warrant Price then in effect shall be made upon the actual issue of such
Common Stock upon conversion or exchange of such Common Stock
Equivalents.

    

    (f)
  Superseding
Adjustment. If, at any time after any adjustment of the Warrant Price
then in effect shall have been made pursuant to Section 4(e) as the result of
any issuance of Common Stock Equivalents, and such Common Stock Equivalents, or
the right of conversion or exchange in such Common Stock Equivalents, shall
expire, and all of such or the right of conversion or exchange with respect to
all of such Common Stock Equivalents shall not have been converted or exercised,
then, on the date that such right of conversion or exchange of the Common Stock
Equivalents shall be set to expire, such previous adjustment shall be rescinded
and annulled and the Warrant Price then in effect shall be adjusted to the
Warrant Price in effect immediately prior to the issuance of such Common Stock
Equivalents, subject to any further adjustments pursuant to this Section
4.

     

    (g)
  Other
Provisions Applicable to Adjustments under this Section. The following
provisions shall be applicable to the making of adjustments of the number of
shares of Common Stock for which this Warrant is exercisable and the Warrant
Price then in effect provided for in this Section 4:

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

    (i)
  Computation of
Consideration. To the extent that any Additional Shares of Common Stock
or any Common Stock Equivalents (or any warrants or other rights therefore)
shall be issued for cash consideration, the consideration received by the Issuer
therefore shall be the amount of the cash received by the Issuer therefore, or,
if such Additional Shares of Common Stock or Common Stock Equivalents are
offered by the Issuer for subscription, the subscription price, or, if such
Additional Shares of Common Stock or Common Stock Equivalents are sold to
underwriters or dealers for public offering without a subscription offering, the
initial public offering price (in any such case subtracting any amounts paid or
receivable for accrued interest or accrued dividends and without taking into
account any compensation, discounts or expenses paid or incurred by the Issuer
for and in the underwriting of, or otherwise in connection with, the issuance
thereof). In connection with any merger or consolidation in which the Issuer is
the surviving corporation (other than any consolidation or merger in which the
previously outstanding shares of Common Stock of the Issuer shall be changed to
or exchanged for the stock or other securities of another corporation), the
amount of consideration therefore shall be, deemed to be the fair value, as
determined reasonably and in good faith by the Board, and acceptable to the
Holder, of such portion of the assets and business of the non-surviving
corporation as the Board may determine to be attributable to such shares of
Common Stock or Common Stock Equivalents, as the case may be. The consideration
for any Additional Shares of Common Stock issuable pursuant to any warrants or
other rights to subscribe for or purchase the same shall be the consideration
received by the Issuer for issuing such warrants or other rights plus the
additional consideration payable to the Issuer upon exercise of such warrants or
other rights. The consideration for any Additional Shares of Common Stock
issuable pursuant to the terms of any Common Stock Equivalents shall be the
consideration received by the Issuer for issuing warrants or other rights to
subscribe for or purchase such Common Stock Equivalents, plus the consideration
paid or payable to the Issuer in respect of the subscription for or purchase of
such Common Stock Equivalents, plus the additional consideration, if any,
payable to the Issuer upon the exercise of the right of conversion or exchange
in such Common Stock Equivalents. In the event of any consolidation or merger of
the Issuer in which the Issuer is not the surviving corporation or in which the
previously outstanding shares of Common Stock of the Issuer shall be changed
into or exchanged for the stock or other securities of another corporation, or
in the event of any sale of all or substantially all of the assets of the Issuer
for stock or other securities of any corporation, the Issuer shall be deemed to
have issued a number of shares of its Common Stock for stock or securities or
other property of the other corporation computed on the basis of the actual
exchange ratio on which the transaction was predicated, and for a consideration
equal to the fair market value on the date of such transaction of all such stock
or securities or other property of the other corporation. In the event any
consideration received by the Issuer for any securities consists of property
other than cash, the fair market value thereof at the time of issuance or as
otherwise applicable shall be as determined in good faith by the Board. In the
event Common Stock is issued with other shares or securities or other assets of
the Issuer for consideration which covers both, the consideration computed as
provided in this Section 4(g)(i) shall be allocated among such securities and
assets as determined in good faith by the Board.

     

    (ii)
  When
Adjustments to Be Made. The adjustments required by this Section 4 shall
be made whenever and as often as any specified event requiring an adjustment
shall occur, except that any adjustment of the number of shares of Common Stock
for which this Warrant is exercisable that would otherwise be required may be
postponed (except in the case of a subdivision or combination of shares of the
Common Stock, as provided for in Section 4(b)) up to, but not beyond the date of
exercise if such adjustment either by itself or with other adjustments not
previously made adds or subtracts less than one percent (1%) of the shares of
Common Stock for which this Warrant is exercisable immediately prior to the
making of such adjustment. Any adjustment representing a change of less than
such minimum amount (except as aforesaid) which is postponed shall be carried
forward and made as soon as such adjustment, together with other adjustments
required by this Section 4 and not previously made, would result in a minimum
adjustment or on the date of exercise. For the purpose of any adjustment, any
specified event shall be deemed to have occurred at the close of business on the
date of its occurrence.

     

    (iii)
  Fractional
Interests. In computing adjustments under this Section 4, fractional
interests in Common Stock shall be taken into account to the nearest one
one-hundredth (1/100th) of a share.

     

    (iv)
  When Adjustment
Not Required. If the Issuer shall take a record of the holders of its
Common Stock for the purpose of entitling them to receive a dividend or
distribution or subscription or purchase rights and shall, thereafter and before
the distribution to stockholders thereof, legally abandon its plan to pay or
deliver such dividend, distribution, subscription or purchase rights, then
thereafter no adjustment shall be required by reason of the taking of such
record and any such adjustment previously made in respect thereof shall be
rescinded and annulled.

     

    (h)
  Form of Warrant
after Adjustments. The form of this Warrant need not be changed because
of any adjustments in the Warrant Price or the number and kind of Securities
purchasable upon the exercise of this Warrant.

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

     

                (i)
  Escrow of
Warrant Stock. If after any property becomes distributable pursuant to
this Section 4 by reason of the taking of any record of the holders of Common
Stock, but prior to the occurrence of the event for which such record is taken,
and the Holder exercises this Warrant, any shares of Common Stock issuable upon
exercise by reason of such adjustment shall be deemed the last shares of Common
Stock for which this Warrant is exercised (notwithstanding any other provision
to the contrary herein) and such shares or other property shall be held in
escrow for the Holder by the Issuer to be issued to the Holder upon and to the
extent that the event actually takes place, upon payment of the current Warrant
Price. Notwithstanding any other provision to the contrary herein, if the event
for which such record was taken fails to occur or is rescinded, then such
escrowed shares shall be cancelled by the Issuer and escrowed property
returned.

     

    5.  
Notice of
Adjustments. Whenever the Warrant Price or Warrant Share Number shall be
adjusted pursuant to Section 4 hereof (for purposes of this Section 5, each an
“adjustment”),
the Issuer shall cause its Chief Financial Officer or other authorized officer,
as the case may be, to prepare and execute a certificate setting forth, in
reasonable detail, the event requiring the adjustment, the amount of the
adjustment, the method by which such adjustment was calculated (including a
description of the basis on which the Board made any determination hereunder),
and the Warrant Price and Warrant Share Number after giving effect to such
adjustment, and shall cause copies of such certificate to be delivered to the
Holder of this Warrant promptly after each adjustment. Any dispute between the
Issuer and the Holder of this Warrant with respect to the matters set forth in
such certificate may at the option of the Holder of this Warrant be submitted to
an Independent Appraiser, provided that the
Issuer shall have ten (10) days after receipt of notice from such Holder of its
selection of such firm to object thereto, in which case such Holder shall select
another such firm and the Issuer shall have no such right of objection. The
Independent Appraiser selected by the Holder of this Warrant as provided in the
preceding sentence shall be instructed to deliver a written opinion as to such
matters to the Issuer and such Holder within thirty (30) days after submission
to it of such dispute. Such opinion shall be final and binding on the parties
hereto. The reasonable costs and expenses of the Independent Appraiser in making
such determination shall be paid by the Issuer, in the event the Holder's
calculation was correct, or by the Holder, in the event the Issuer’s calculation
was correct, or equally by the Issuer and the Holder in the event that neither
the Issuer's or the Holder's calculation was correct.

     

    6.  
Fractional
Shares. No fractional shares of Warrant Stock will be issued in
connection with any exercise hereof, but in lieu of such fractional shares, the
Issuer shall, at its option, (a) pay an amount in cash equal to the Warrant
Price multiplied by such fraction or (b) round the number of shares to be issued
upon exercise up to the nearest whole number of shares.

     

    7.  
Ownership Cap and
Exercise Restriction. Notwithstanding anything to the contrary set forth
in this Warrant, at no time may the Holder exercise this Warrant if the number
of shares of Common Stock to be issued pursuant to such exercise would cause the
number of shares of Common Stock beneficially owned by the Holder at such time
to exceed, when aggregated with all other shares of Common Stock owned by the
Holder and its affiliates at such time, the number of shares of Common Stock
which would result in the Holder, its affiliates, any investment manager having
discretionary investment authority over the accounts or assets of the Holder and
its affiliates, or any other persons whose beneficial ownership of Common Stock
would be aggregated for purposes of Section 13(d) and Section 16 of the Exchange
Act, beneficially owning (as determined in accordance with Section 13(d) of the
Exchange Act and the rules thereunder) in excess of 9.9% of the then issued and
outstanding shares of Common Stock; provided, however, that upon
the Holder providing the Issuer with sixty-one (61) days notice (pursuant to
this certificate) (the “Waiver Notice”) that
the Holder would like to waive this Section 7 with regard to any or all shares
of Common Stock issuable upon exercise of this Warrant, this Section 7 shall be
of no force or effect with regard to those shares of Common Stock referenced in
the Waiver Notice; provided, further, that during
the sixty-one (61) day period prior to the Termination Date, the Holder may
waive this Section 7 by providing a Waiver Notice at any time during such
sixty-one (61) day period; provided, further, that any
Waiver Notice provided during the sixty-one (61) day period prior to the
Termination Date will not be effective until the Termination Date.

     

    8.  
Registration
Rights. The Holder of this Warrant is entitled to the benefit of certain
registration rights with respect to the shares of Warrant Stock issuable upon
the exercise of this Warrant pursuant to that certain Subscription Agreement, of
even date herewith, by and among the Issuer and Persons listed on Schedule I thereto
(the “Subscription
Agreement”) and the registration rights with respect to the shares of
Warrant Stock issuable upon the exercise of this Warrant by any subsequent
Holder may only be assigned in accordance with the terms and provisions
therein.

     

    9.  
Definitions.
For the purposes of this Warrant, the following terms have the following
meanings:

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

     “Additional Shares of Common
Stock” means all shares of Common Stock issued by the Issuer after the
Original Issue Date, and all shares of Other Common, if any, issued by the
Issuer after the Original Issue Date, except: (i) securities issued (other than
for cash) in connection with a strategic merger, acquisition, or consolidation,
provided that the issuance of such securities in connection with such strategic
merger, acquisition, or consolidation has been approved in advance by the
Majority Holders, (ii) securities issued pursuant to the conversion or exercise
of convertible or exercisable securities issued or outstanding on or prior to
the date of the Subscription Agreement or issued pursuant to the Subscription
Agreement (so long as the conversion or exercise price in such securities are
not amended to lower such price and/or adversely affect the Holders) which have
previously been disclosed to the Holder, (iii) the Warrant Stock, (iv)
securities issued in connection with bona fide strategic license agreements or
other partnering arrangements so long as such issuances are not for the purpose
of raising capital and provided that the issuance of such securities in
connection with such bona fide strategic license agreements or other partnering
arrangements has been approved in advance by the Majority Holders, (v) Common
Stock issued or the issuance or grants of options to purchase Common Stock
pursuant to the Issuer’s equity incentive plans outstanding as they exist on the
date of the Subscription Agreement, (vi) the issuance or grants of options to
purchase Common Stock to employees, officers or directors of the Issuer pursuant
to any equity incentive plan duly adopted by the Board or a committee thereof
established for such purpose so long as such issuances in the aggregate do not
exceed ten percent (10%) of the total number of then issued and outstanding
shares of Common Stock, unless approved by the Majority Holders, and the
specified price at which the options may be exercised is equal to or greater
than the Per Share Market Value as of the date of such grant, (vii) any
warrants, shares of Common Stock or other securities issued to a placement agent
and its designees for the transactions contemplated by the Subscription
Agreement, which have been previously disclosed to the Holder or in any other
sales of the Issuer’s securities and any securities issued in connection with
any financial advisory agreements of the Issuer and the shares of Common Stock
issued upon exercise of any such warrants or conversions of any such other
securities and (viii) any warrants, shares of Common Stock or other securities
issued to any advisor or consultant to the Company that are outstanding as of
the date of the Subscription Agreement, or are to be issued pursuant to the
terms of an engagement letter or other contractual obligation as of the date of
the Subscription Agreement, and which have previously been disclosed to the
Holder. .

     

    “Board” shall mean the
Board of Directors of the Issuer.

     

    “Capital Stock” means
and includes (i) any and all shares, interests, participations or other
equivalents of or interests in (however designated) corporate stock, including,
without limitation, shares of preferred or preference stock, (ii) all
partnership interests (whether general or limited) in any Person which is a
partnership, (iii) all membership interests or limited liability company
interests in any limited liability company, and (iv) all equity or ownership
interests in any Person of any other type.

     

    “Certificate of
Incorporation” means the Certificate of Incorporation of the Issuer as in
effect on the Original Issue Date, and as hereafter from time to time amended,
modified, supplemented or restated in accordance with the terms hereof and
thereof and pursuant to applicable law.

     

    “Common Stock” means
the Common Stock, $0.00001 par value per share, of the Issuer and any other
Capital Stock into which such stock may hereafter be changed.

     

    “Common Stock
Equivalent” means any Convertible Security or warrant, option or other
right to subscribe for or purchase any Additional Shares of Common Stock or any
Convertible Security.

    

    “Convertible
Securities” means evidences of Indebtedness, shares of Capital Stock or
other Securities which are or may be at any time convertible into or
exchangeable for Additional Shares of Common Stock. The term “Convertible
Security” means one of the Convertible Securities.

     

    “Governmental
Authority” means any governmental, regulatory or self-regulatory entity,
department, body, official, authority, commission, board, agency or
instrumentality, whether federal, state or local, and whether domestic or
foreign.

    
      
         

      

      
        10

        
          

        

      

      
         

      

    

     

    “Holders” mean the
Persons who shall from time to time own any Warrant. The term “Holder” means one
of the Holders.

     

    “Independent
Appraiser” means a nationally recognized or major regional investment
banking firm or firm of independent certified public accountants of recognized
standing (which may be the firm that regularly examines the financial statements
of the Issuer) that is regularly engaged in the business of appraising the
Capital Stock or assets of corporations or other entities as going concerns, and
which is not affiliated with either the Issuer or the Holder of any
Warrant.

     

    “Issuer” means Weikang
Bio-Technology Group Company, Inc., a Nevada corporation, and its
successors.

     

    “Majority Holders”
means at any time the Holders of Warrants exercisable for a majority of the
shares of Warrant Stock issuable under the Warrants at the time
outstanding,.

     

    “Original Issue Date”
means January 20, 2010.

    

    “OTC Bulletin Board”
means the over-the-counter electronic bulletin board.

    

    “Other Common” means
any other Capital Stock of the Issuer of any class which shall be authorized at
any time after the date of this Warrant (other than Common Stock) and which
shall have the right to participate in the distribution of earnings and assets
of the Issuer without limitation as to amount.

     

    “Outstanding Common
Stock” means, at any given time, the aggregate amount of outstanding
shares of Common Stock, assuming full exercise, conversion or exchange (as
applicable) of all options, warrants and other Securities which are convertible
into or exercisable or exchangeable for, and any right to subscribe for, shares
of Common Stock that are outstanding at such time.

     

    “Person” means an
individual, corporation, limited liability company, partnership, joint stock
company, trust, unincorporated organization, joint venture, Governmental
Authority or other entity of whatever nature.

     

    “Per Share Market
Value” means on any particular date (a) the last closing price per share
of the Common Stock on such date on the Trading Market or another registered
national stock exchange on which the Common Stock is then listed, or if there is
no closing price on such date, then the closing bid price on such date, or if
there is no closing bid price on such date, then the closing price on such
exchange or quotation system on the date nearest preceding such date, or (b) if
the Common Stock is not listed then on a Trading Market or any registered
national stock exchange, the last closing price for a share of Common Stock in
the over-the-counter market, as reported by the Trading Market or any registered
national stock exchange or in the National Quotation Bureau Incorporated or
similar organization or agency succeeding to its functions of reporting prices)
at the close of business on such date, or if there is no closing price on such
date, then the closing bid price on such date, or (c) if the Common Stock is not
then reported by the Trading Market or any registered national stock exchange or
in the National Quotation Bureau Incorporated (or similar organization or agency
succeeding to its functions of reporting prices), then the average of the “Pink
Sheet” quotes for the five (5) Trading Days preceding such date of
determination, or (d) if the Common Stock is not then publicly traded the fair
market value of a share of Common Stock as determined by an Independent
Appraiser selected in good faith by the Majority Holders; provided, however , that the
Issuer, after receipt of the determination by such Independent Appraiser, shall
have the right to select an additional Independent Appraiser, in which case, the
fair market value shall be equal to the average of the determinations by each
such Independent Appraiser; and provided, further, that all
determinations of the Per Share Market Value shall be appropriately adjusted for
any stock dividends, stock splits or other similar transactions during such
period. The determination of fair market value by an Independent Appraiser shall
be based upon the fair market value of the Issuer determined on a going concern
basis as between a willing buyer and a willing seller and taking into account
all relevant factors determinative of value, and shall be final and binding on
all parties. In determining the fair market value of any shares of Common Stock,
no consideration shall be given to any restrictions on transfer of the Common
Stock imposed by agreement or by federal or state securities laws, or to the
existence or absence of, or any limitations on, voting
rights. 

    
      
         

      

      
        11

        
          

        

      

      
         

      

    

    

    “Subscription
Agreement” means the Subscription Agreement dated as of January 20, 2010,
among the Issuer and the Purchasers.

     

    “Purchasers” means the
purchasers of the Common Stock and Warrants (as defined in the Subscription
Agreement), issued by the Issuer pursuant to the Subscription
Agreement.

     

    “Securities” means any
debt or equity securities of the Issuer, whether now or hereafter authorized,
any instrument convertible into or exchangeable for Securities or a Security,
and any option, warrant or other right to purchase or acquire any Security.
“Security” means one of the Securities.

     

    “Securities Act” means
the Securities Act of 1933, as amended, or any similar federal statute then in
effect.

     

    “Subsidiary” means any
corporation at least 50% of whose outstanding Voting Stock shall at the time be
owned directly or indirectly by the Issuer or by one or more of its
Subsidiaries, or by the Issuer and one or more of its Subsidiaries.

     

    “Term” has the meaning
specified in Section 1 hereof.

     

    “Trading Day” means
(a) a day on which the Common Stock is traded on a Trading Market, or (b) if the
Common Stock is not traded on a Trading Market, a day on which the Common Stock
is quoted in the over-the-counter market as reported by the National Quotation
Bureau Incorporated (or any similar organization or agency succeeding its
functions of reporting prices); provided , however , that in the
event that the Common Stock is not listed or quoted as set forth in (a) or (b)
hereof, then Trading Day shall mean any day except Saturday, Sunday and any day
which shall be a legal holiday or a day on which banking institutions in the
State of New York are authorized or required by law or other government action
to close.

     

    “Trading Market” means
the following markets or exchanges on which the Common Stock is listed or quoted
for trading on the date in question: the American Stock Exchange, the Nasdaq
Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the
New York Stock Exchange or the OTC Bulletin Board.

     

    “Voting Stock” means,
as applied to the Capital Stock of any corporation, Capital Stock of any class
or classes (however designated) having ordinary voting power for the election of
a majority of the members of the Board of Directors (or other governing body) of
such corporation, other than Capital Stock having such power only by reason of
the happening of a contingency.

     

    “VWAP” means, for any
date, the price determined by the first of the following clauses that applies:
(a) if the Common Stock is then listed or quoted on a Trading Market, the daily
volume weighted average price of the Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed
or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m.
New York City time to 4:00 p.m. New York City time); (b) if the OTC Bulletin
Board is not a Trading Market, the volume weighted average price of the Common
Stock for such date (or the nearest preceding date) on the OTC Bulletin Board;
(c) if the Common Stock is not then listed or quoted on the OTC Bulletin Board
and if prices for the Common Stock are then reported in the "Pink Sheets"
published by Pink Sheets, LLC (or a similar organization or agency succeeding to
its functions of reporting prices), the most recent bid price per share of the
Common Stock so reported; or (d) in all other cases, the fair market value of a
share of Common Stock as determined by an Independent Appraiser selected in good
faith by the Majority Holders, the fees and expenses of which shall be paid by
the Issuer.

     

    “Warrants” means the
Warrants issued and sold pursuant to the Subscription Agreement, including,
without limitation, this Warrant, and any other warrants of like tenor issued in
substitution or exchange for any thereof pursuant to the provisions of Section
2(c), 2(d) or 2(e) hereof or of any of such other Warrants.

    
      
         

      

      
        12

        
          

        

      

      
         

      

    

     

    “Warrant Price”
initially means $3.00 per share as such price may be adjusted from time to time
as shall result from the adjustments specified in this Warrant, including
Section 4 hereto.

     

    “Warrant Share Number”
means at any time the aggregate number of shares of Warrant Stock which may at
such time be purchased upon exercise of this Warrant, after giving effect to all
prior adjustments and increases to such number made or required to be made under
the terms hereof.

    

    “Warrant Stock” means
Common Stock issuable upon exercise of any Warrant or Warrants or otherwise
issuable pursuant to any Warrant or Warrants.

     

    10.
  Other
Notices. In case at any time:

     

    (a)
  the Issuer shall make any distributions to the holders of Common Stock;
or

     

    (b)
  the Issuer shall authorize the granting to all holders of its Common
Stock of rights to subscribe for or purchase any shares of Capital Stock of any
class or other rights; or

     

    (c)
  there shall be any reclassification of the Capital Stock of the Issuer;
or

     

    (d)
  there shall be any capital reorganization by the Issuer; or

     

    (e)
  there shall be any (i) consolidation or merger involving the Issuer or
(ii) sale, transfer or other disposition of all or substantially all of the
Issuer’s property, assets or business (except a merger or other reorganization
in which the Issuer shall be the surviving corporation and its shares of Capital
Stock shall continue to be outstanding and unchanged and except a consolidation,
merger, sale, transfer or other disposition involving a wholly-owned
Subsidiary); or

     

    (f)
  there shall be a voluntary or involuntary dissolution, liquidation or
winding-up of the Issuer or any partial liquidation of the Issuer or
distribution to holders of Common Stock;

     

    then, in
each of such cases, the Issuer shall give written notice to the Holder of the
date on which (i) the books of the Issuer shall close or a record shall be taken
for such dividend, distribution or subscription rights or (ii) such
reorganization, reclassification, consolidation, merger, disposition,
dissolution, liquidation or winding-up, as the case may be, shall take place.
Such notice also shall specify the date as of which the holders of Common Stock
of record shall participate in such dividend, distribution or subscription
rights, or shall be entitled to exchange their certificates for Common Stock for
securities or other property deliverable upon such reorganization,
reclassification, consolidation, merger, disposition, dissolution, liquidation
or winding-up, as the case may be. Such notice shall be given at least twenty
(20) days prior to the action in question and not less than ten (10) days prior
to the record date or the date on which the Issuer’s transfer books are closed
in respect thereto. This Warrant entitles the Holder to receive copies of all
financial and other information distributed or required to be distributed to the
holders of the Common Stock.

     

    11.
  Amendment and
Waiver. Any term, covenant, agreement or condition in this Warrant may be
amended, or compliance therewith may be waived (either generally or in a
particular instance and either retroactively or prospectively), by a written
instrument or written instruments executed by the Issuer and the Majority
Holders; provided , however , that no
such amendment or waiver shall reduce the Warrant Share Number, increase the
Warrant Price, shorten the period during which this Warrant may be exercised or
modify any provision of this Section 11 without the consent of the Holder of
this Warrant. No consideration shall be offered or paid to any person to amend
or consent to a waiver or modification of any provision of this Warrant unless
the same consideration is also offered to all holders of the
Warrants.

    
      
         

      

      
        13

        
          

        

      

      
         

      

    

    12.
  Governing Law;
Jurisdiction. This Warrant shall be governed by and construed in
accordance with the internal laws of the State of New York, without giving
effect to any of the conflicts of law principles which would result in the
application of the substantive law of another jurisdiction. This Warrant shall
not be interpreted or construed with any presumption against the party causing
this Warrant to be drafted. The Issuer and the Holder agree that venue for any
dispute arising under this Warrant will lie exclusively in the state or federal
courts located in New York, and the parties irrevocably waive any right to raise
forum non conveniens or any other argument that New York is not the proper
venue. The Issuer and the Holder irrevocably consent to personal jurisdiction in
the state and federal courts of the state of New York. The Issuer and the Holder
consent to process being served in any such suit, action or proceeding by
mailing a copy thereof via registered or certified mail or overnight delivery
(with evidence of delivery) to such party at the address in effect for notices
to it under this Warrant and agree that such service shall constitute good and
sufficient service of process and notice thereof. Nothing in this Section 12
shall affect or limit any right to serve process in any other manner permitted
by law. The Issuer and the Holder hereby agree that the prevailing party in any
suit, action or proceeding arising out of or relating to this Warrant or the
Subscription Agreement, shall be entitled to reimbursement for reasonable legal
fees from the non-prevailing party. The parties hereby waive all rights to a
trial by jury.

     

    13.
  Notices.
Any notice, demand, request, waiver or other communication required or permitted
to be given hereunder shall be in writing and shall be effective (a) immediately
upon hand delivery, telecopy or facsimile at the address or number designated
below (if delivered on a business day during normal business hours where such
notice is to be received), or the first business day following such delivery (if
delivered other than on a business day during normal business hours where such
notice is to be received) or (b) on the second business day following the date
of mailing by express courier service, fully prepaid, addressed to such address,
or upon actual receipt of such mailing, whichever shall first occur. The
addresses for such communications shall be:

    

    
      	
              If
      to the Issuer:

               

            	
               

              Weikang
      Bio-Technology Group Company, Inc.

              Attn:
      Mr. Yin Wang, Chairman

              No.
      365 Chengde Street, Daowai District, Harbin

              Heilongjiang
      Province, PRC 150020

              facsimile:
      +

            
	 
      	 
      
	
              with
      copies (which copies

              shall
      not constitute notice)

              to:

            	 
      
	 
      	 
      
	
              If to any Holder:

            	
              At
      the address of such Holder set forth on Exhibit A to this Agreement, with
      copies to Holder’s counsel as set forth on Exhibit A or as specified in
      writing by such Holder with copies to:

            
	 
      	 
      
	
              with
      copies (which copies

              shall
      not constitute notice)

              to:

               

               

            	
               

              Anslow
      & Jaclin LLP

              195
      Route 9 South, 2nd
      Floor

              Manalapan,
      NJ 07726

              Attn:
      Kristina M. Trauger, Esq.

              Tel.
      No.: (732) 409-1212

              Fax
      No: (732) 577-1188

            

    

     

    Any party
hereto may from time to time change its address for notices by giving at least
ten (10) days written notice of such changed address to the other party
hereto.

    
      
         

      

      
        14

        
          

        

      

      
         

      

    

     

    14.
  Warrant
Agent. The Issuer may, by written notice to the Holder of this Warrant,
appoint an agent having an office in New York, New York for the purpose of
issuing shares of Warrant Stock on the exercise of this Warrant pursuant to
subsection (b) of Section 2 hereof, exchanging this Warrant pursuant to
subsection (d) of Section 2 hereof or replacing this Warrant pursuant to
subsection (d) of Section 3 hereof, or any of the foregoing, and thereafter any
such issuance, exchange or replacement, as the case may be, shall be made at
such office by such agent.

     

    15.   Mandatory Exercise
Provision.  In the event that (i) the VWAP for the previous
twenty (20) Trading Days is above $4.50, and (iii) the average daily volume of
the Issuer’s Common Stock for the previous twenty (20) Trading Days exceeds
20,000 shares per day, then the Issuer, upon ten (10) business days prior
written notice (the “Notice Period”) given
to the Holders within three business days immediately following the end of such
twenty (20) Trading Day period, may require the exercise of this Warrant
pursuant to the provisions of Section (2) herein (the “Mandatory Exercise”);
provided that
(i) the Issuer simultaneously requires the exercise of all Series A Warrants on
the same terms, (ii) all of the shares of Common Stock issuable hereunder are
registered pursuant to an effective Registration Statement (as defined in the
Registration Rights Agreement) which at the time of such Mandatory Exercise is
not suspended and for which no stop order is in effect, and pursuant to which
the Holder is able to sell such shares of Common Stock at all times during the
Notice Period and (iii) this Warrant is fully exercisable for the full amount of
Warrant Stock covered hereby notwithstanding the ownership cap and restrictions
set forth in Section 7 hereof (the “Ownership Cap”); provided that the
Mandatory Exercise shall be subject to the Ownership Cap and the Company shall
only be entitled to require the Mandatory Exercise of the warrant up to the
Ownership Cap. Notwithstanding any such notice by the Issuer, the Holder shall
have the right to exercise all, or any portion, of this Warrant prior to the end
of the Notice Period.  The Company shall have the right, but not the
obligation, to exercise the Mandatory Exercise at any time, and from time to
time in accordance with this Section 15, but in no event shall the Company
exercise the right more than once in any thirty (30) Trading Day
period.

    

    16.
  Remedies. The Issuer
stipulates that the remedies at law of the Holder of this Warrant in the event
of any default or threatened default by the Issuer in the performance of or
compliance with any of the terms of this Warrant are not and will not be
adequate and that, to the fullest extent permitted by law, such terms may be
specifically enforced by a decree for the specific performance of any agreement
contained herein or by an injunction against a violation of any of the terms
hereof or otherwise.

     

    17.
  Successors and
Assigns. This Warrant and the rights evidenced hereby shall inure to the
benefit of and be binding upon the successors and assigns of the Issuer, the
Holder hereof and (to the extent provided herein) the Holders of Warrant Stock
issued pursuant hereto, and shall be enforceable by any such Holder or Holder of
Warrant Stock.

     

    18.
  Modification
and Severability. If, in any action before any court or agency legally
empowered to enforce any provision contained herein, any provision hereof is
found to be unenforceable, then such provision shall be deemed modified to the
extent necessary to make it enforceable by such court or agency. If any such
provision is not enforceable as set forth in the preceding sentence, the
unenforceability of such provision shall not affect the other provisions of this
Warrant, but this Warrant shall be construed as if such unenforceable provision
had never been contained herein.

    

    19.    No Rights as
Stockholders. Prior to the exercise of this Warrant, the Holder shall not
have or exercise any rights as a stockholder of the Issuer by virtue of its
ownership of this Warrant.

     

    20.
  Headings. The
headings of the Sections of this Warrant are for convenience of reference only
and shall not, for any purpose, be deemed a part of this Warrant.

     

    [REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]

    
      
         

      

      
        15

        
          

        

      

      
         

      

    

     

    IN
WITNESS WHEREOF, the Issuer has executed this Warrant as of the day and year
first above written.

    

    
      
        
          	 
      	
                  WEIKANG
      BIO-TECHNOLOGY GROUP COMPANY, INC.

                
	 
      	 
      	 
      
	 
      	
                  By:

                	 
      
	 
      	 
      	
                  Name:

                
	 
      	 
      	
                  Title:

                

        

      

    

     

    
      
         

      

      
        16

        
          

        

      

      
         

      

    

     

    EXERCISE
FORM

    SERIES A
WARRANT

     

    WEIKANG
BIO-TECHNOLOGY GROUP COMPANY, INC.

     

    The
undersigned _______________, pursuant to the provisions of the within Warrant,
hereby elects to purchase _____ shares of Common Stock of
________________________________ covered by the within Warrant.

     

    
      	
              Dated:

            	 
      	 
      	
              Signature

            	 
      
	 
      	 
      	 
      	 
      	 
      
	 
      	 
      	 
      	
              Address

            	 
      
	 
      	 
      	 
      	 
      	 
      
	 
      	 
      	 
      	 
      	 
      

    

     

    Number of
shares of Common Stock beneficially owned or deemed beneficially owned by the
Holder on the date of Exercise: _________________________

     

    The
undersigned is an “accredited investor” as defined in Regulation D under the
Securities Act of 1933, as amended.

     

    The
undersigned intends that payment of the Warrant Price shall be made as (check
one):

     

    Cash
Exercise_______

     

    Cashless
Exercise_______

     

    If the
Holder has elected a Cash Exercise, the Holder shall pay the sum of $________ by
certified or official bank check (or via wire transfer) to the Issuer in
accordance with the terms of the Warrant.

     

    If the
Holder has elected a Cashless Exercise, a certificate shall be issued to the
Holder for the number of shares equal to the whole number portion of the product
of the calculation set forth below, which is ___________. The Issuer shall pay a
cash adjustment in respect of the fractional portion of the product of the
calculation set forth below in an amount equal to the product of the fractional
portion of such product and the Per Share Market Value on the date of exercise,
which product is ____________.

     

    
      
        	 
      	
                X =
      Y - (A)(Y)

              
	
                B

              

      

    

     

    Where:

     

    The
number of shares of Common Stock to be issued to the Holder
__________________(“X”).

     

    The
number of shares of Common Stock purchasable upon exercise of all of the Warrant
or, if only a portion of the Warrant is being exercised, the portion of the
Warrant being exercised ___________________________ (“Y”).

     

    The
Warrant Price ______________ (“A”).

     

    The Per
Share Market Value of one share of Common Stock _______________________
(“B”)

    
      
         

      

      
        17

        
          

        

      

      
         

      

    

    

    ASSIGNMENT

     

    FOR VALUE
RECEIVED, _________________ hereby sells, assigns and transfers unto
__________________ the within Warrant and all rights evidenced thereby and does
irrevocably constitute and appoint _____________, attorney, to transfer the said
Warrant on the books of the within named corporation.

     

    
      	
              Dated:

            	 
      	 
      	
              Signature

            	 
      
	 
      	 
      	 
      	 
      	 
      
	 
      	 
      	 
      	
              Address

            	 
      
	 
      	 
      	 
      	 
      	 
      
	 
      	 
      	 
      	 
      	 
      

    

     

    PARTIAL
ASSIGNMENT

     

    FOR VALUE
RECEIVED, _________________ hereby sells, assigns and transfers unto
__________________ the right to purchase _________ shares of Warrant Stock
evidenced by the within Warrant together with all rights therein, and does
irrevocably constitute and appoint ___________________, attorney, to transfer
that part of the said Warrant on the books of the within named
corporation.

     

    
      	
              Dated:

            	 
      	 
      	
              Signature

            	 
      
	 
      	 
      	 
      	 
      	 
      
	 
      	 
      	 
      	
              Address

            	 
      
	 
      	 
      	 
      	 
      	 
      
	 
      	 
      	 
      	 
      	 
      

    

     

    FOR USE
BY THE ISSUER ONLY:

     

    This
Warrant No. W-___ canceled (or transferred or exchanged) this _____ day of
___________, _____, shares of Common Stock issued therefor in the name of
_______________, Warrant No. W-_____ issued for ____ shares of Common Stock in
the name of _______________.

    
      
         

      

      
        18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}]]